A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
Substances which lower blood glucose levels.
Glucose in blood.
Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
Minor hemoglobin components of human erythrocytes designated A1a, A1b, and A1c. Hemoglobin A1c is most important since its sugar moiety is glucose covalently bound to the terminal amino acid of the beta chain. Since normal glycohemoglobin concentrations exclude marked blood glucose fluctuations over the preceding three to four weeks, the concentration of glycosylated hemoglobin A is a more reliable index of the blood sugar average over a long period of time.
KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE.
Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY.
Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.
Abnormally high BLOOD GLUCOSE level.
A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg).
VASCULAR DISEASES that are associated with DIABETES MELLITUS.
Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN.
The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy (DIABETES, GESTATIONAL) which resolves at the end of pregnancy.
An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals.
A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA.
An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight (kg)/height squared (m2). BMI correlates with body fat (ADIPOSE TISSUE). Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 (underweight); 18.5-24.9 (normal); 25.0-29.9 (overweight); 30.0 and above (obese). (National Center for Health Statistics, Centers for Disease Control and Prevention)
Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).
A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
Sulfonylurea compounds are a class of medications used in the treatment of diabetes mellitus type 2 that promote insulin secretion from pancreatic beta-cells by closing ATP-sensitive potassium channels in their membranes.
A type of pancreatic cell representing about 50-80% of the islet cells. Beta cells secrete INSULIN.
A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.
A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.
A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.
Self evaluation of whole blood glucose levels outside the clinical laboratory. A digital or battery-operated reflectance meter may be used. It has wide application in controlling unstable insulin-dependent diabetes.
Elements of limited time intervals, contributing to particular results or situations.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin.
The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
Abstaining from all food.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
A pyridoxal-phosphate protein that catalyzes the alpha-decarboxylation of L-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining GAMMA-AMINOBUTYRIC ACID levels in normal nervous tissues. The brain enzyme also acts on L-cysteate, L-cysteine sulfinate, and L-aspartate. EC 4.1.1.15.
Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
A diet prescribed in the treatment of diabetes mellitus, usually limited in the amount of sugar or readily available carbohydrate. (Dorland, 27th ed)
The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
A strain of non-obese diabetic mice developed in Japan that has been widely studied as a model for T-cell-dependent autoimmune insulin-dependent diabetes mellitus in which insulitis is a major histopathologic feature, and in which genetic susceptibility is strongly MHC-linked.
PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.
A cluster of metabolic risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome X include excess ABDOMINAL FAT; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. (from AHA/NHLBI/ADA Conference Proceedings, Circulation 2004; 109:551-556)
A set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.
A strain of Rattus norvegicus which is a model for spontaneous insulin-dependent diabetes mellitus (DIABETES MELLITUS, INSULIN-DEPENDENT).
Alloxan is a chemical compound, specifically an organic compound, that is used in scientific research to induce diabetes in laboratory animals by destroying their insulin-producing cells in the pancreas.
THIAZOLES with two keto oxygens. Members are insulin-sensitizing agents which overcome INSULIN RESISTANCE by activation of the peroxisome proliferator activated receptor gamma (PPAR-gamma).
The term "United States" in a medical context often refers to the country where a patient or study participant resides, and is not a medical term per se, but relevant for epidemiological studies, healthcare policies, and understanding differences in disease prevalence, treatment patterns, and health outcomes across various geographic locations.
Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances.
The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality.
Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor.
The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
An amino sugar formed when glucose non-enzymatically reacts with the N-terminal amino group of proteins. The fructose moiety is derived from glucose by the "classical" Amadori rearrangement.
Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor.
A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed)
Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release.
## I'm sorry for any confusion, but "Japan" is not a medical term or concept. It is a country located in Asia, known as Nihon-koku or Nippon-koku in Japanese, and is renowned for its unique culture, advanced technology, and rich history. If you have any questions related to medical topics, I would be happy to help answer them!
Triglycerides are the most common type of fat in the body, stored in fat cells and used as energy; they are measured in blood tests to assess heart disease risk, with high levels often resulting from dietary habits, obesity, physical inactivity, smoking, and alcohol consumption.
Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
Common foot problems in persons with DIABETES MELLITUS, caused by any combination of factors such as DIABETIC NEUROPATHIES; PERIPHERAL VASCULAR DISEASES; and INFECTION. With the loss of sensation and poor circulation, injuries and infections often lead to severe foot ulceration, GANGRENE and AMPUTATION.
The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases.
A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.
Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable.
A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
Conditions with excess LIPIDS in the blood.
Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
A peptide of 36 or 37 amino acids that is derived from PROGLUCAGON and mainly produced by the INTESTINAL L CELLS. GLP-1(1-37 or 1-36) is further N-terminally truncated resulting in GLP-1(7-37) or GLP-1-(7-36) which can be amidated. These GLP-1 peptides are known to enhance glucose-dependent INSULIN release, suppress GLUCAGON release and gastric emptying, lower BLOOD GLUCOSE, and reduce food intake.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.
The appearance of an abnormally large amount of GLUCOSE in the urine, such as more than 500 mg/day in adults. It can be due to HYPERGLYCEMIA or genetic defects in renal reabsorption (RENAL GLYCOSURIA).
Performance of activities or tasks traditionally performed by professional health care providers. The concept includes care of oneself or one's family and friends.
Individuals whose ancestral origins are in the southeastern and eastern areas of the Asian continent.
The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
Maintenance of a constant blood glucose level by perfusion or infusion with glucose or insulin. It is used for the study of metabolic rates (e.g., in glucose, lipid, amino acid metabolism) at constant glucose concentration.
A distribution in which a variable is distributed like the sum of the squares of any given independent random variable, each of which has a normal distribution with mean of zero and variance of one. The chi-square test is a statistical test based on comparison of a test statistic to a chi-square distribution. The oldest of these tests are used to detect whether two or more population distributions differ from one another.
Typical way of life or manner of living characteristic of an individual or group. (From APA, Thesaurus of Psychological Index Terms, 8th ed)
The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.
A pancreatic beta-cell hormone that is co-secreted with INSULIN. It displays an anorectic effect on nutrient metabolism by inhibiting gastric acid secretion, gastric emptying and postprandial GLUCAGON secretion. Islet amyloid polypeptide can fold into AMYLOID FIBRILS that have been found as a major constituent of pancreatic AMYLOID DEPOSITS.
The time frame after a meal or FOOD INTAKE.
Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.
Individual members of North American ethnic groups with ancient historic ancestral origins in Asia.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
The transference of pancreatic islets within an individual, between individuals of the same species, or between individuals of different species.
The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome.
A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596)
A pancreatic polypeptide of about 110 amino acids, depending on the species, that is the precursor of insulin. Proinsulin, produced by the PANCREATIC BETA CELLS, is comprised sequentially of the N-terminal B-chain, the proteolytically removable connecting C-peptide, and the C-terminal A-chain. It also contains three disulfide bonds, two between A-chain and B-chain. After cleavage at two locations, insulin and C-peptide are the secreted products. Intact proinsulin with low bioactivity also is secreted in small amounts.
A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.
A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511)
A hereditary condition characterized by multiple symptoms including those of DIABETES INSIPIDUS; DIABETES MELLITUS; OPTIC ATROPHY; and DEAFNESS. This syndrome is also known as DIDMOAD (first letter of each word) and is usually associated with VASOPRESSIN deficiency. It is caused by mutations in gene WFS1 encoding wolframin, a 100-kDa transmembrane protein.
The number of males and females in a given population. The distribution may refer to how many men or women or what proportion of either in the group. The population is usually patients with a specific disease but the concept is not restricted to humans and is not restricted to medicine.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
A 30-kDa COMPLEMENT C1Q-related protein, the most abundant gene product secreted by FAT CELLS of the white ADIPOSE TISSUE. Adiponectin modulates several physiological processes, such as metabolism of GLUCOSE and FATTY ACIDS, and immune responses. Decreased plasma adiponectin levels are associated with INSULIN RESISTANCE; TYPE 2 DIABETES MELLITUS; OBESITY; and ATHEROSCLEROSIS.
The teaching or training of patients concerning their own health needs.
Peptides which stimulate INSULIN release from the PANCREATIC BETA CELLS following oral nutrient ingestion, or postprandially.
A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi).
The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance.
Poisonous animal secretions forming fluid mixtures of many different enzymes, toxins, and other substances. These substances are produced in specialized glands and secreted through specialized delivery systems (nematocysts, spines, fangs, etc.) for disabling prey or predator.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.
Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol.
The frequency of different ages or age groups in a given population. The distribution may refer to either how many or what proportion of the group. The population is usually patients with a specific disease but the concept is not restricted to humans and is not restricted to medicine.
NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Creatinine is a waste product that's generated from muscle metabolism, typically filtered through the kidneys and released in urine, with increased levels in blood indicating impaired kidney function.
A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
A type of diabetes mellitus that is characterized by severe INSULIN RESISTANCE and LIPODYSTROPHY. The latter may be generalized, partial, acquired, or congenital (LIPODYSTROPHY, CONGENITAL GENERALIZED).
A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.
Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)
The age, developmental stage, or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual.
Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol.
Regular course of eating and drinking adopted by a person or animal.
A group of the D-related HLA antigens found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases.
The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.
An infant during the first month after birth.
Products derived from the nonenzymatic reaction of GLUCOSE and PROTEINS in vivo that exhibit a yellow-brown pigmentation and an ability to participate in protein-protein cross-linking. These substances are involved in biological processes relating to protein turnover and it is believed that their excessive accumulation contributes to the chronic complications of DIABETES MELLITUS.
Studies in which variables relating to an individual or group of individuals are assessed over a period of time.
Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
A subspecialty of internal medicine concerned with the metabolism, physiology, and disorders of the ENDOCRINE SYSTEM.
Therapy with two or more separate preparations given for a combined effect.
A tricyclo bridged hydrocarbon.
The transference of a pancreas from one human or animal to another.
Two populations of Zucker rats have been cited in research--the "fatty" or obese and the lean. The "fatty" rat (Rattus norvegicus) appeared as a spontaneous mutant. The obese condition appears to be due to a single recessive gene.
Decrease in existing BODY WEIGHT.
I'm sorry for any confusion, but "Arizona" is a proper noun and refers to a state in the southwestern United States, not a medical term or condition. It would not have a medical definition.
A range of values for a variable of interest, e.g., a rate, constructed so that this range has a specified probability of including the true value of the variable.
Physical activity which is usually regular and done with the intention of improving or maintaining PHYSICAL FITNESS or HEALTH. Contrast with PHYSICAL EXERTION which is concerned largely with the physiologic and metabolic response to energy expenditure.
Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression.
Inhaling and exhaling the smoke of burning TOBACCO.
A numerical system of measuring the rate of BLOOD GLUCOSE generation from a particular food item as compared to a reference item, such as glucose = 100. Foods with higher glycemic index numbers create greater blood sugar swings.
A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.
Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.
An inbred strain of Long-Evans rats that develops hyperglycemia, hyperinsulinemia, and mild obesity, mostly in males, that resembles non-insulin-dependent diabetes mellitus in humans. It was developed from outbred Long-Evans stock in 1983.

Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. (1/16781)

Dysfunction of the pancreatic beta cell is an important defect in the pathogenesis of type 2 diabetes, although its exact relationship to the insulin resistance is unclear. To determine whether insulin signaling has a functional role in the beta cell we have used the Cre-loxP system to specifically inactivate the insulin receptor gene in the beta cells. The resultant mice exhibit a selective loss of insulin secretion in response to glucose and a progressive impairment of glucose tolerance. These data indicate an important functional role for the insulin receptor in glucose sensing by the pancreatic beta cell and suggest that defects in insulin signaling at the level of the beta cell may contribute to the observed alterations in insulin secretion in type 2 diabetes.  (+info)

Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade. (2/16781)

BACKGROUND: In patients with insulin-dependent diabetes mellitus (IDDM) and overt nephropathy glomerular barrier size-selectivity progressively deteriorates with time and is effectively improved by angiotensin converting enzyme (ACE) inhibition. Whether similar glomerular functional changes develop in proteinuric patients with non-insulin-dependent diabetes mellitus (NIDDM), and whether antihypertensive agents can favorably affect glomerular filtration of macromolecules in these patients, has not been documented yet. METHODS: We investigated renal hemodynamics and fractional clearance of neutral dextrans of graded sizes, in nine proteinuric patients with NIDDM and renal biopsy findings of typical diabetic glomerulopathy. Six healthy volunteers served as controls. We also investigated the effects of an ACE inhibitor and of a calcium channel blocker, both given in doses targeted to achieve a comparable level of systemic blood pressure control, on glomerular hemodynamics and sieving function. Theoretical analysis of glomerular macromolecule transport was adopted to evaluate intrinsic glomerular membrane permeability properties. RESULTS: Fractional clearance of large macromolecules (42 to 66 A in radius) was significantly higher in diabetic patients than in controls, and the distribution of membrane pore radii was calculated to be shifted towards larger pore sizes in diabetics (mean radius increased from 55 to 60 A). Despite effective blood pressure control, neither antihypertensive affected glomerular hemodynamics to any significant extent. Fractional clearance of dextrans, as well as of albumin and IgG, and total urinary proteins were not modified by either treatments. CONCLUSIONS: These data indicate that patients with NIDDM and overt nephropathy develop abnormalities in size-selective function of the glomerular barrier and, at variance to IDDM, such changes were not ameliorated either by ACE inhibition or calcium channel blockade.  (+info)

Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. (3/16781)

BACKGROUND: The plasma concentrations of total homocysteine (tHcy) and total cysteine (tCys) are determined by intracellular metabolism and by renal plasma clearance, and we hypothesized that glomerular filtration is a major determinant of plasma tHcy and tCys. We studied the relationships between the glomerular filtration rate (GFR) and plasma tHcy and tCys in populations of diabetic patients with particularly wide ranges of GFR. METHODS: We measured GFR, urine albumin excretion rate (UAER), plasma tHcy, tCys, methionine, vitamin B12, folate, C-peptide, and routine parameters in 50 insulin-dependent diabetes mellitus (IDDM) and 30 non-insulin-dependent diabetes mellitus (NIDDM) patients. All patients underwent intensive insulin treatment and had a serum creatinine concentration below 115 micromol/liter. RESULTS: Mean plasma tHcy in diabetic patients (0.1 micromol/liter) was lower than in normal persons (11.1 micromol/liter, P = 0.0014). Mean plasma tCys in diabetic patients (266.1 micromol/liter) was also lower than in normal persons (281.9 micromol/liter, P = 0.0005). Seventy-three percent of the diabetic patients had relative hyperfiltration. Plasma tHcy and tCys were closely and independently associated with GFR, serum folate, and serum B12. However, plasma tHcy was not independently associated with any of the 22 other variables tested, including age, serum creatinine concentration, UAER, total daily insulin dose, and glycemic control. CONCLUSIONS: Glomerular filtration rate is an independent determinant of plasma tHcy and tCys concentrations, and GFR is rate limiting for renal clearance of both homocysteine and cysteine in diabetic patients without overt nephropathy. Declining GFR explains the age-related increase in plasma tHcy, and hyperfiltration explains the lower than normal mean plasma tHcy and tCys concentrations in populations of diabetic patients.  (+info)

Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. (4/16781)

We are conducting a genome scan at an average resolution of 10 centimorgans (cM) for type 2 diabetes susceptibility genes in 716 affected sib pairs from 477 Finnish families. To date, our best evidence for linkage is on chromosome 20 with potentially separable peaks located on both the long and short arms. The unweighted multipoint maximum logarithm of odds score (MLS) was 3.08 on 20p (location, chi = 19.5 cM) under an additive model, whereas the weighted MLS was 2.06 on 20q (chi = 57 cM, recurrence risk,lambda(s) = 1. 25, P = 0.009). Weighted logarithm of odds scores of 2.00 (chi = 69.5 cM, P = 0.010) and 1.92 (chi = 18.5 cM, P = 0.013) were also observed. Ordered subset analyses based on sibships with extreme mean values of diabetes-related quantitative traits yielded sets of families who contributed disproportionately to the peaks. Two-hour glucose levels in offspring of diabetic individuals gave a MLS of 2. 12 (P = 0.0018) at 9.5 cM. Evidence from this and other studies suggests at least two diabetes-susceptibility genes on chromosome 20. We have also screened the gene for maturity-onset diabetes of the young 1, hepatic nuclear factor 4-a (HNF-4alpha) in 64 affected sibships with evidence for high chromosomal sharing at its location on chromosome 20q. We found no evidence that sequence changes in this gene accounted for the linkage results we observed.  (+info)

Incidence of analgesic nephropathy in Berlin since 1983. (5/16781)

BACKGROUND: Phenacetin was removed from the German market in 1986 and was replaced mainly in analgesic compounds by acetaminophen. Our objective was to examine the effect of this measure on the incidence of analgesic nephropathy in light of the changes in other end-stage renal diseases. METHODS: We therefore compared the proportion of renal diseases in all patients starting dialysis treatment during three 18-month periods: 4/1982-9/1983 (n=57); 1/1991-6/1992 (n=81); and 10/1995-3/1997 (n=76). RESULTS: On the one hand, the proportion of end-stage analgesic nephropathy decreased significantly from 30% in 1981-1982 to 21% in 1991-1992 and 12% in 1995-1997 (P=0.01). On the other hand, type II diabetes increased significantly from 7% to 22% (P=0.01) and 29%, (P=0.001). Using the chi2 distribution test to analyze the frequencies of seven diseases at three different time intervals, however, showed that the changes in renal-disease proportions between 1982-1983, 1991-1992 and 1995-1997 were not significantly independent. There was a significant median age increase from 52 years (CI0.95 44-58) in 1982-1983 to 63 (CI0.95 55-67) in 1991-1992 and 63 (CI0.95 60-66) in 1995-1997 (P=0.003) for all patients starting dialysis but not for those with analgesic nephropathy [59 (55-71) vs 64 (53-67) and 61 (50-72); n.s.]. CONCLUSION: The decrease of end-stage analgesic nephropathy since 1983 may be partially due to the removal of phenacetin from the German market in 1986. However, considering the general increase in numbers of dialysis patients, their higher age and the increased incidence of type II diabetes, the decrease in analgesic nephropathy is not a statistically significant independent variable. Altered admittance policies for dialysis treatment have yielded a new pattern of renal-disease proportion which interferes with changes in the incidence of analgesic nephropathy.  (+info)

Abysmal prognosis of patients with type 2 diabetes entering dialysis. (6/16781)

INTRODUCTION: The importance of non-insulin-dependent diabetes mellitus (type II diabetes) as a leading cause of end-stage renal disease is now widely recognized. The purpose of this study was to assess life-prognosis and its predictors in a cohort of patients newly entering dialysis. MATERIAL AND METHODS: Eighty-four consecutive type II diabetes patients (40% of all patients) starting dialysis between 01/01/95 and 31/12/96 were studied retrospectively, focusing on clinical data at inception and life-prognosis after a mean follow-up of 211 days. Patients were divided into three groups, according to onset of renal failure: acute 11% (9/84), chronic 61% (51/84) and acutely aggravated chronic renal failure 28% (25/84). RESULTS: Patients (mean age 67 years) had long-standing diabetes (mean duration approximately 15 years), heavy proteinuria (approximately 3 g/24h) and diabetic retinopathy (67%). The average creatinine clearance (Cockcroft's formula) was 13 ml/min. Cardiovascular diseases were highly prevalent at the start of dialysis: history of myocardial infarction (26%), angina (36%) and acute left ventricular dysfunction (67%). More than 80% of the patients underwent the first session dialysis under emergency conditions, a situation in part related to late referral to the nephrology division (63% for chronic patients). A great majority of the patients were overhydrated when starting dialysis, as evidenced by the average weight loss of 6 kg, during the first month of dialysis, required to reach dry weight. Nearly 64% of the patients presented high blood pressure (> 140/90 mmHg) when starting dialysis despite antihypertensive therapy (mean: 2.3 drugs). The outcome of this type II diabetes population was dramatic: 32% (27/84) died after a mean follow-up of 211 days, mostly from cardiovascular diseases. The rate of recovery of renal function was low in both the acute and the acutely aggravated renal failure group (30% and 24%, respectively). Of note, iatrogenic nephrotoxic agents accounted for renal function impairment in nearly 30% of patients. CONCLUSION: Our observational study illustrates the high burden of cardiovascular diseases contrasting with sub-optimal cardiovascular therapeutic interventions in type II diabetes patients entering dialysis. Factors aggravating renal failure were mainly iatrogenic, and therefore largely avoidable. Late referral generally implied a poor clinical condition at the start of dialysis.  (+info)

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. (7/16781)

Protein tyrosine phosphatase-1B (PTP-1B) has been implicated in the negative regulation of insulin signaling. Disruption of the mouse homolog of the gene encoding PTP-1B yielded healthy mice that, in the fed state, had blood glucose concentrations that were slightly lower and concentrations of circulating insulin that were one-half those of their PTP-1B+/+ littermates. The enhanced insulin sensitivity of the PTP-1B-/- mice was also evident in glucose and insulin tolerance tests. The PTP-1B-/- mice showed increased phosphorylation of the insulin receptor in liver and muscle tissue after insulin injection in comparison to PTP-1B+/+ mice. On a high-fat diet, the PTP-1B-/- and PTP-1B+/- mice were resistant to weight gain and remained insulin sensitive, whereas the PTP-1B+/+ mice rapidly gained weight and became insulin resistant. These results demonstrate that PTP-1B has a major role in modulating both insulin sensitivity and fuel metabolism, thereby establishing it as a potential therapeutic target in the treatment of type 2 diabetes and obesity.  (+info)

Angiotensin II receptor type 1 gene expression in human glomerulonephritis and diabetes mellitus. (8/16781)

The renin-angiotensin system plays an important role in the progression of chronic renal disease. Although the expression of renin and angiotensin-converting enzyme in experimental and human renal disease has been well characterized, no information is available regarding human angiotensin type 1 (AT1) receptor expression. The net effect of renin depends on AT1 receptor expression, among other factors. Receptor expression was determined in renal biopsy samples (including all tissue components) and isolated glomeruli from patients with glomerulonephritis (GN) or diabetic nephropathy (non-insulin-dependent diabetes mellitus). Biopsy samples and isolated glomeruli from tumor-free tissue from tumor nephrectomies served as controls. Human AT1 receptor gene expression was determined by quantitative reverse transcription-PCR, using an AT1 receptor deletion mutant as the internal standard. In whole biopsy samples from 37 patients with various types of GN, AT1 receptor mRNA levels were lower, compared with nine control biopsy samples (P < 0.001). AT1 receptor mRNA levels were also significantly lower (P < 0.001) in eight samples from patients with diabetic nephropathy. In microdissected glomeruli, AT1 receptor gene expression was significantly lower in samples from patients (n = 22) with various types of GN, compared with 12 microdissected tumor nephrectomy control samples (P < 0.0023). It is concluded that AT1 receptor mRNA expression is low in glomeruli of patients with chronic renal disease. This may reflect a regulatory response to (inappropriately) high intrarenal angiotensin II concentrations.  (+info)

Diabetes Mellitus, Type 2 is a metabolic disorder characterized by high blood glucose (or sugar) levels resulting from the body's inability to produce sufficient amounts of insulin or effectively use the insulin it produces. This form of diabetes usually develops gradually over several years and is often associated with older age, obesity, physical inactivity, family history of diabetes, and certain ethnicities.

In Type 2 diabetes, the body's cells become resistant to insulin, meaning they don't respond properly to the hormone. As a result, the pancreas produces more insulin to help glucose enter the cells. Over time, the pancreas can't keep up with the increased demand, leading to high blood glucose levels and diabetes.

Type 2 diabetes is managed through lifestyle modifications such as weight loss, regular exercise, and a healthy diet. Medications, including insulin therapy, may also be necessary to control blood glucose levels and prevent long-term complications associated with the disease, such as heart disease, nerve damage, kidney damage, and vision loss.

Diabetes Mellitus, Type 1 is a chronic autoimmune disease characterized by the destruction of insulin-producing beta cells in the pancreas, leading to an absolute deficiency of insulin. This results in an inability to regulate blood glucose levels, causing hyperglycemia (high blood sugar). Type 1 diabetes typically presents in childhood or early adulthood, although it can develop at any age. It is usually managed with regular insulin injections or the use of an insulin pump, along with monitoring of blood glucose levels and adjustments to diet and physical activity. Uncontrolled type 1 diabetes can lead to serious complications such as kidney damage, nerve damage, blindness, and cardiovascular disease.

Diabetes Mellitus is a chronic metabolic disorder characterized by elevated levels of glucose in the blood (hyperglycemia) due to absolute or relative deficiency in insulin secretion and/or insulin action. There are two main types: Type 1 diabetes, which results from the autoimmune destruction of pancreatic beta cells leading to insulin deficiency, and Type 2 diabetes, which is associated with insulin resistance and relative insulin deficiency.

Type 1 diabetes typically presents in childhood or young adulthood, while Type 2 diabetes tends to occur later in life, often in association with obesity and physical inactivity. Both types of diabetes can lead to long-term complications such as damage to the eyes, kidneys, nerves, and cardiovascular system if left untreated or not well controlled.

The diagnosis of diabetes is usually made based on fasting plasma glucose levels, oral glucose tolerance tests, or hemoglobin A1c (HbA1c) levels. Treatment typically involves lifestyle modifications such as diet and exercise, along with medications to lower blood glucose levels and manage associated conditions.

Hypoglycemic agents are a class of medications that are used to lower blood glucose levels in the treatment of diabetes mellitus. These medications work by increasing insulin sensitivity, stimulating insulin release from the pancreas, or inhibiting glucose production in the liver. Examples of hypoglycemic agents include sulfonylureas, meglitinides, biguanides, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors, and GLP-1 receptor agonists. It's important to note that the term "hypoglycemic" refers to a condition of abnormally low blood glucose levels, but in this context, the term is used to describe agents that are used to treat high blood glucose levels (hyperglycemia) associated with diabetes.

Blood glucose, also known as blood sugar, is the concentration of glucose in the blood. Glucose is a simple sugar that serves as the main source of energy for the body's cells. It is carried to each cell through the bloodstream and is absorbed into the cells with the help of insulin, a hormone produced by the pancreas.

The normal range for blood glucose levels in humans is typically between 70 and 130 milligrams per deciliter (mg/dL) when fasting, and less than 180 mg/dL after meals. Levels that are consistently higher than this may indicate diabetes or other metabolic disorders.

Blood glucose levels can be measured through a variety of methods, including fingerstick blood tests, continuous glucose monitoring systems, and laboratory tests. Regular monitoring of blood glucose levels is important for people with diabetes to help manage their condition and prevent complications.

Diabetic neuropathies refer to a group of nerve disorders that are caused by diabetes. High blood sugar levels can injure nerves throughout the body, but diabetic neuropathies most commonly affect the nerves in the legs and feet.

There are four main types of diabetic neuropathies:

1. Peripheral neuropathy: This is the most common type of diabetic neuropathy. It affects the nerves in the legs and feet, causing symptoms such as numbness, tingling, burning, or shooting pain.
2. Autonomic neuropathy: This type of neuropathy affects the autonomic nerves, which control involuntary functions such as heart rate, blood pressure, digestion, and bladder function. Symptoms may include dizziness, fainting, digestive problems, sexual dysfunction, and difficulty regulating body temperature.
3. Proximal neuropathy: Also known as diabetic amyotrophy, this type of neuropathy affects the nerves in the hips, thighs, or buttocks, causing weakness, pain, and difficulty walking.
4. Focal neuropathy: This type of neuropathy affects a single nerve or group of nerves, causing symptoms such as weakness, numbness, or pain in the affected area. Focal neuropathies can occur anywhere in the body, but they are most common in the head, torso, and legs.

The risk of developing diabetic neuropathies increases with the duration of diabetes and poor blood sugar control. Other factors that may contribute to the development of diabetic neuropathies include genetics, age, smoking, and alcohol consumption.

Glycosylated Hemoglobin A, also known as Hemoglobin A1c or HbA1c, is a form of hemoglobin that is bound to glucose. It is formed in a non-enzymatic glycation reaction with glucose in the blood. The amount of this hemoglobin present in the blood is proportional to the average plasma glucose concentration over the previous 8-12 weeks, making it a useful indicator for monitoring long-term blood glucose control in people with diabetes mellitus.

In other words, HbA1c reflects the integrated effects of glucose regulation over time and is an important clinical marker for assessing glycemic control and risk of diabetic complications. The normal range for HbA1c in individuals without diabetes is typically less than 5.7%, while a value greater than 6.5% is indicative of diabetes.

Diabetic nephropathy is a kidney disease that occurs as a complication of diabetes. It is also known as diabetic kidney disease (DKD). This condition affects the ability of the kidneys to filter waste and excess fluids from the blood, leading to their accumulation in the body.

Diabetic nephropathy is caused by damage to the small blood vessels in the kidneys, which can occur over time due to high levels of glucose in the blood. This damage can lead to scarring and thickening of the kidney's filtering membranes, reducing their ability to function properly.

Symptoms of diabetic nephropathy may include proteinuria (the presence of protein in the urine), edema (swelling in the legs, ankles, or feet due to fluid retention), and hypertension (high blood pressure). Over time, if left untreated, diabetic nephropathy can progress to end-stage kidney disease, which requires dialysis or a kidney transplant.

Preventing or delaying the onset of diabetic nephropathy involves maintaining good control of blood sugar levels, keeping blood pressure under control, and making lifestyle changes such as quitting smoking, eating a healthy diet, and getting regular exercise. Regular monitoring of kidney function through urine tests and blood tests is also important for early detection and treatment of this condition.

Insulin is a hormone produced by the beta cells of the pancreatic islets, primarily in response to elevated levels of glucose in the circulating blood. It plays a crucial role in regulating blood glucose levels and facilitating the uptake and utilization of glucose by peripheral tissues, such as muscle and adipose tissue, for energy production and storage. Insulin also inhibits glucose production in the liver and promotes the storage of excess glucose as glycogen or triglycerides.

Deficiency in insulin secretion or action leads to impaired glucose regulation and can result in conditions such as diabetes mellitus, characterized by chronic hyperglycemia and associated complications. Exogenous insulin is used as a replacement therapy in individuals with diabetes to help manage their blood glucose levels and prevent long-term complications.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

Obesity is a complex disease characterized by an excess accumulation of body fat to the extent that it negatively impacts health. It's typically defined using Body Mass Index (BMI), a measure calculated from a person's weight and height. A BMI of 30 or higher is indicative of obesity. However, it's important to note that while BMI can be a useful tool for identifying obesity in populations, it does not directly measure body fat and may not accurately reflect health status in individuals. Other factors such as waist circumference, blood pressure, cholesterol levels, and blood sugar levels should also be considered when assessing health risks associated with weight.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

Diabetes complications refer to a range of health issues that can develop as a result of poorly managed diabetes over time. These complications can affect various parts of the body and can be classified into two main categories: macrovascular and microvascular.

Macrovascular complications include:

* Cardiovascular disease (CVD): People with diabetes are at an increased risk of developing CVD, including coronary artery disease, peripheral artery disease, and stroke.
* Peripheral arterial disease (PAD): This condition affects the blood vessels that supply oxygen and nutrients to the limbs, particularly the legs. PAD can cause pain, numbness, or weakness in the legs and may increase the risk of amputation.

Microvascular complications include:

* Diabetic neuropathy: This is a type of nerve damage that can occur due to prolonged high blood sugar levels. It commonly affects the feet and legs, causing symptoms such as numbness, tingling, or pain.
* Diabetic retinopathy: This condition affects the blood vessels in the eye and can cause vision loss or blindness if left untreated.
* Diabetic nephropathy: This is a type of kidney damage that can occur due to diabetes. It can lead to kidney failure if not managed properly.

Other complications of diabetes include:

* Increased risk of infections, particularly skin and urinary tract infections.
* Slow healing of wounds, which can increase the risk of infection and amputation.
* Gum disease and other oral health problems.
* Hearing impairment.
* Sexual dysfunction.

Preventing or managing diabetes complications involves maintaining good blood sugar control, regular monitoring of blood glucose levels, following a healthy lifestyle, and receiving routine medical care.

I couldn't find a medical definition specifically for "Diabetes Mellitus, Experimental." However, I can provide you with information about experimental diabetes research and its relevance to understanding the disease.

Experimental diabetes models are used in biomedical research to study the pathophysiology of diabetes mellitus and to test potential therapies or treatments. These models can be broadly categorized into two types: chemically-induced and genetically modified.

1. Chemically-induced diabetes models: These involve administering chemicals, such as alloxan or streptozotocin, to animals (commonly mice or rats) to destroy their pancreatic β-cells, which produce insulin. This results in hyperglycemia and symptoms similar to those seen in type 1 diabetes in humans.
2. Genetically modified diabetes models: These involve altering the genes of animals (commonly mice) to create a diabetes phenotype. Examples include non-obese diabetic (NOD) mice, which develop an autoimmune form of diabetes similar to human type 1 diabetes, and various strains of obese mice with insulin resistance, such as ob/ob or db/db mice, which model aspects of type 2 diabetes.

These experimental models help researchers better understand the mechanisms behind diabetes development and progression, identify new therapeutic targets, and test potential treatments before moving on to human clinical trials. However, it's essential to recognize that these models may not fully replicate all aspects of human diabetes, so findings from animal studies should be interpreted with caution.

Gestational diabetes is a type of diabetes that occurs during pregnancy. It is characterized by an increase in blood sugar levels that begins or is first recognized during pregnancy. The condition usually develops around the 24th week of gestation and is caused by the body's inability to produce enough insulin to meet the increased demands of pregnancy.

Gestational diabetes typically resolves after delivery, but women who have had gestational diabetes are at an increased risk of developing type 2 diabetes later in life. It is important for women with gestational diabetes to manage their blood sugar levels during pregnancy to reduce the risk of complications for both the mother and the baby.

Management of gestational diabetes may include lifestyle modifications such as dietary changes and exercise, as well as monitoring blood sugar levels and potentially using insulin or other medications to control blood sugar levels. Regular prenatal care is essential for women with gestational diabetes to ensure that their blood sugar levels are properly managed and to monitor the growth and development of the fetus.

Hyperglycemia is a medical term that refers to an abnormally high level of glucose (sugar) in the blood. Fasting hyperglycemia is defined as a fasting blood glucose level greater than or equal to 126 mg/dL (milligrams per deciliter) on two separate occasions. Alternatively, a random blood glucose level greater than or equal to 200 mg/dL in combination with symptoms of hyperglycemia (such as increased thirst, frequent urination, blurred vision, and fatigue) can also indicate hyperglycemia.

Hyperglycemia is often associated with diabetes mellitus, a chronic metabolic disorder characterized by high blood glucose levels due to insulin resistance or insufficient insulin production. However, hyperglycemia can also occur in other conditions such as stress, surgery, infection, certain medications, and hormonal imbalances.

Prolonged or untreated hyperglycemia can lead to serious complications such as diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS), and long-term damage to various organs such as the eyes, kidneys, nerves, and blood vessels. Therefore, it is essential to monitor blood glucose levels regularly and maintain them within normal ranges through proper diet, exercise, medication, and lifestyle modifications.

A Glucose Tolerance Test (GTT) is a medical test used to diagnose prediabetes, type 2 diabetes, and gestational diabetes. It measures how well your body is able to process glucose, which is a type of sugar.

During the test, you will be asked to fast (not eat or drink anything except water) for at least eight hours before the test. Then, a healthcare professional will take a blood sample to measure your fasting blood sugar level. After that, you will be given a sugary drink containing a specific amount of glucose. Your blood sugar levels will be measured again after two hours and sometimes also after one hour.

The results of the test will indicate how well your body is able to process the glucose and whether you have normal, impaired, or diabetic glucose tolerance. If your blood sugar levels are higher than normal but not high enough to be diagnosed with diabetes, you may have prediabetes, which means that you are at increased risk of developing type 2 diabetes in the future.

It is important to note that a Glucose Tolerance Test should be performed under the supervision of a healthcare professional, as high blood sugar levels can be dangerous if not properly managed.

Diabetic angiopathies refer to a group of vascular complications that occur due to diabetes mellitus. Prolonged exposure to high blood sugar levels can damage the blood vessels, leading to various types of angiopathies such as:

1. Diabetic retinopathy: This is a condition where the small blood vessels in the retina get damaged due to diabetes, leading to vision loss or blindness if left untreated.
2. Diabetic nephropathy: In this condition, the kidneys' glomeruli (the filtering units) become damaged due to diabetes, leading to protein leakage and eventually kidney failure if not managed properly.
3. Diabetic neuropathy: This is a type of nerve damage caused by diabetes that can affect various parts of the body, including the legs, feet, and hands, causing numbness, tingling, or pain.
4. Diabetic cardiomyopathy: This is a condition where the heart muscle becomes damaged due to diabetes, leading to heart failure.
5. Diabetic peripheral arterial disease (PAD): In this condition, the blood vessels that supply the legs and feet become narrowed or blocked due to diabetes, leading to pain, cramping, or even gangrene in severe cases.

Overall, diabetic angiopathies are serious complications of diabetes that can significantly impact a person's quality of life and overall health. Therefore, it is crucial for individuals with diabetes to manage their blood sugar levels effectively and undergo regular check-ups to detect any early signs of these complications.

Insulin resistance is a condition in which the body's cells become less responsive to insulin, a hormone produced by the pancreas that regulates blood sugar levels. In response to this decreased sensitivity, the pancreas produces more insulin to help glucose enter the cells. However, over time, the pancreas may not be able to keep up with the increased demand for insulin, leading to high levels of glucose in the blood and potentially resulting in type 2 diabetes, prediabetes, or other health issues such as metabolic syndrome, cardiovascular disease, and non-alcoholic fatty liver disease. Insulin resistance is often associated with obesity, physical inactivity, and genetic factors.

Diabetic retinopathy is a diabetes complication that affects the eyes. It's caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina).

At first, diabetic retinopathy may cause no symptoms or only mild vision problems. Eventually, it can cause blindness. The condition usually affects both eyes.

There are two main stages of diabetic retinopathy:

1. Early diabetic retinopathy. This is when the blood vessels in the eye start to leak fluid or bleed. You might not notice any changes in your vision at this stage, but it's still important to get treatment because it can prevent the condition from getting worse.
2. Advanced diabetic retinopathy. This is when new, abnormal blood vessels grow on the surface of the retina. These vessels can leak fluid and cause severe vision problems, including blindness.

Diabetic retinopathy can be treated with laser surgery, injections of medication into the eye, or a vitrectomy (a surgical procedure to remove the gel-like substance that fills the center of the eye). It's important to get regular eye exams to detect diabetic retinopathy early and get treatment before it causes serious vision problems.

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

The Islets of Langerhans are clusters of specialized cells within the pancreas, an organ located behind the stomach. These islets are named after Paul Langerhans, who first identified them in 1869. They constitute around 1-2% of the total mass of the pancreas and are distributed throughout its substance.

The Islets of Langerhans contain several types of cells, including:

1. Alpha (α) cells: These produce and release glucagon, a hormone that helps to regulate blood sugar levels by promoting the conversion of glycogen to glucose in the liver when blood sugar levels are low.
2. Beta (β) cells: These produce and release insulin, a hormone that promotes the uptake and utilization of glucose by cells throughout the body, thereby lowering blood sugar levels.
3. Delta (δ) cells: These produce and release somatostatin, a hormone that inhibits the release of both insulin and glucagon and helps regulate their secretion in response to changing blood sugar levels.
4. PP cells (gamma or γ cells): These produce and release pancreatic polypeptide, which plays a role in regulating digestive enzyme secretion and gastrointestinal motility.

Dysfunction of the Islets of Langerhans can lead to various endocrine disorders, such as diabetes mellitus, where insulin-producing beta cells are damaged or destroyed, leading to impaired blood sugar regulation.

'Pregnancy in Diabetics' refers to the condition where an individual with pre-existing diabetes mellitus becomes pregnant. This can be further categorized into two types:

1. Pre-gestational diabetes: This is when a woman is diagnosed with diabetes before she becomes pregnant. It includes both Type 1 and Type 2 diabetes. Proper control of blood sugar levels prior to conception and during pregnancy is crucial to reduce the risk of complications for both the mother and the baby.

2. Gestational diabetes: This is when a woman develops high blood sugar levels during pregnancy, typically in the second or third trimester. While it usually resolves after delivery, women with gestational diabetes have a higher risk of developing Type 2 diabetes later in life. Proper management of gestational diabetes is essential to ensure a healthy pregnancy and reduce the risk of complications for both the mother and the baby.

Streptozocin is an antibiotic and antineoplastic agent, which is primarily used in the treatment of metastatic pancreatic islet cell carcinoma (a type of pancreatic cancer). It is a naturally occurring compound produced by the bacterium Streptomyces achromogenes.

Medically, streptozocin is classified as an alkylating agent due to its ability to interact with DNA and RNA, disrupting the growth and multiplication of malignant cells. However, it can also have adverse effects on non-cancerous cells, particularly in the kidneys and pancreas, leading to potential side effects such as nephrotoxicity (kidney damage) and hyperglycemia (high blood sugar).

It is essential that streptozocin be administered under the supervision of a healthcare professional, who can monitor its effectiveness and potential side effects. The drug is typically given through intravenous infusion, with the dosage and duration tailored to individual patient needs and treatment responses.

Diabetic ketoacidosis (DKA) is a serious metabolic complication characterized by the triad of hyperglycemia, metabolic acidosis, and increased ketone bodies. It primarily occurs in individuals with diabetes mellitus type 1, but it can also be seen in some people with diabetes mellitus type 2, particularly during severe illness or surgery.

The condition arises when there is a significant lack of insulin in the body, which impairs the ability of cells to take up glucose for energy production. As a result, the body starts breaking down fatty acids to produce energy, leading to an increase in ketone bodies (acetoacetate, beta-hydroxybutyrate, and acetone) in the bloodstream. This process is called ketosis.

In DKA, the excessive production of ketone bodies results in metabolic acidosis, which is characterized by a lower than normal pH level in the blood (< 7.35) and an elevated serum bicarbonate level (< 18 mEq/L). The hyperglycemia in DKA is due to both increased glucose production and decreased glucose utilization by cells, which can lead to severe dehydration and electrolyte imbalances.

Symptoms of diabetic ketoacidosis include excessive thirst, frequent urination, nausea, vomiting, abdominal pain, fatigue, fruity breath odor, and altered mental status. If left untreated, DKA can progress to coma and even lead to death. Treatment typically involves administering insulin, fluid replacement, and electrolyte management in a hospital setting.

Body Mass Index (BMI) is a measure used to assess whether a person has a healthy weight for their height. It's calculated by dividing a person's weight in kilograms by the square of their height in meters. Here is the medical definition:

Body Mass Index (BMI) = weight(kg) / [height(m)]^2

According to the World Health Organization, BMI categories are defined as follows:

* Less than 18.5: Underweight
* 18.5-24.9: Normal or healthy weight
* 25.0-29.9: Overweight
* 30.0 and above: Obese

It is important to note that while BMI can be a useful tool for identifying weight issues in populations, it does have limitations when applied to individuals. For example, it may not accurately reflect body fat distribution or muscle mass, which can affect health risks associated with excess weight. Therefore, BMI should be used as one of several factors when evaluating an individual's health status and risk for chronic diseases.

Hypertension is a medical term used to describe abnormally high blood pressure in the arteries, often defined as consistently having systolic blood pressure (the top number in a blood pressure reading) over 130 mmHg and/or diastolic blood pressure (the bottom number) over 80 mmHg. It is also commonly referred to as high blood pressure.

Hypertension can be classified into two types: primary or essential hypertension, which has no identifiable cause and accounts for about 95% of cases, and secondary hypertension, which is caused by underlying medical conditions such as kidney disease, hormonal disorders, or use of certain medications.

If left untreated, hypertension can lead to serious health complications such as heart attack, stroke, heart failure, and chronic kidney disease. Therefore, it is important for individuals with hypertension to manage their condition through lifestyle modifications (such as healthy diet, regular exercise, stress management) and medication if necessary, under the guidance of a healthcare professional.

A prediabetic state, also known as impaired glucose tolerance or prediabetes, is a metabolic condition where blood sugar levels are higher than normal but not high enough to meet the diagnostic criteria for diabetes. It is often characterized by insulin resistance and beta-cell dysfunction, which can lead to an increased risk of developing type 2 diabetes, cardiovascular disease, and other complications if left untreated.

In the prediabetic state, fasting plasma glucose levels are between 100 and 125 mg/dL (5.6-6.9 mmol/L), or hemoglobin A1c (HbA1c) levels are between 5.7% and 6.4%. Lifestyle modifications, such as regular exercise, healthy eating habits, and weight loss, can help prevent or delay the progression of prediabetes to diabetes.

Glucose intolerance is a condition in which the body has difficulty processing and using glucose, or blood sugar, effectively. This results in higher than normal levels of glucose in the blood after eating, particularly after meals that are high in carbohydrates. Glucose intolerance can be an early sign of developing diabetes, specifically type 2 diabetes, and it may also indicate other metabolic disorders such as prediabetes or insulin resistance.

In a healthy individual, the pancreas produces insulin to help regulate blood sugar levels by facilitating glucose uptake in muscles, fat tissue, and the liver. When someone has glucose intolerance, their body may not produce enough insulin, or their cells may have become less responsive to insulin (insulin resistance), leading to impaired glucose metabolism.

Glucose intolerance can be diagnosed through various tests, including the oral glucose tolerance test (OGTT) and hemoglobin A1c (HbA1c) test. Treatment for glucose intolerance often involves lifestyle modifications such as weight loss, increased physical activity, and a balanced diet with reduced sugar and refined carbohydrate intake. In some cases, medication may be prescribed to help manage blood sugar levels more effectively.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

Hypoglycemia is a medical condition characterized by an abnormally low level of glucose (sugar) in the blood. Generally, hypoglycemia is defined as a blood glucose level below 70 mg/dL (3.9 mmol/L), although symptoms may not occur until the blood sugar level falls below 55 mg/dL (3.0 mmol/L).

Hypoglycemia can occur in people with diabetes who are taking insulin or medications that increase insulin production, as well as those with certain medical conditions such as hormone deficiencies, severe liver illnesses, or disorders of the adrenal glands. Symptoms of hypoglycemia include sweating, shaking, confusion, rapid heartbeat, and in severe cases, loss of consciousness or seizures.

Hypoglycemia is typically treated by consuming fast-acting carbohydrates such as fruit juice, candy, or glucose tablets to rapidly raise blood sugar levels. If left untreated, hypoglycemia can lead to serious complications, including brain damage and even death.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

Cardiovascular diseases (CVDs) are a class of diseases that affect the heart and blood vessels. They are the leading cause of death globally, according to the World Health Organization (WHO). The term "cardiovascular disease" refers to a group of conditions that include:

1. Coronary artery disease (CAD): This is the most common type of heart disease and occurs when the arteries that supply blood to the heart become narrowed or blocked due to the buildup of cholesterol, fat, and other substances in the walls of the arteries. This can lead to chest pain, shortness of breath, or a heart attack.
2. Heart failure: This occurs when the heart is unable to pump blood efficiently to meet the body's needs. It can be caused by various conditions, including coronary artery disease, high blood pressure, and cardiomyopathy.
3. Stroke: A stroke occurs when the blood supply to a part of the brain is interrupted or reduced, often due to a clot or a ruptured blood vessel. This can cause brain damage or death.
4. Peripheral artery disease (PAD): This occurs when the arteries that supply blood to the limbs become narrowed or blocked, leading to pain, numbness, or weakness in the legs or arms.
5. Rheumatic heart disease: This is a complication of untreated strep throat and can cause damage to the heart valves, leading to heart failure or other complications.
6. Congenital heart defects: These are structural problems with the heart that are present at birth. They can range from mild to severe and may require medical intervention.
7. Cardiomyopathy: This is a disease of the heart muscle that makes it harder for the heart to pump blood efficiently. It can be caused by various factors, including genetics, infections, and certain medications.
8. Heart arrhythmias: These are abnormal heart rhythms that can cause the heart to beat too fast, too slow, or irregularly. They can lead to symptoms such as palpitations, dizziness, or fainting.
9. Valvular heart disease: This occurs when one or more of the heart valves become damaged or diseased, leading to problems with blood flow through the heart.
10. Aortic aneurysm and dissection: These are conditions that affect the aorta, the largest artery in the body. An aneurysm is a bulge in the aorta, while a dissection is a tear in the inner layer of the aorta. Both can be life-threatening if not treated promptly.

It's important to note that many of these conditions can be managed or treated with medical interventions such as medications, surgery, or lifestyle changes. If you have any concerns about your heart health, it's important to speak with a healthcare provider.

A cohort study is a type of observational study in which a group of individuals who share a common characteristic or exposure are followed up over time to determine the incidence of a specific outcome or outcomes. The cohort, or group, is defined based on the exposure status (e.g., exposed vs. unexposed) and then monitored prospectively to assess for the development of new health events or conditions.

Cohort studies can be either prospective or retrospective in design. In a prospective cohort study, participants are enrolled and followed forward in time from the beginning of the study. In contrast, in a retrospective cohort study, researchers identify a cohort that has already been assembled through medical records, insurance claims, or other sources and then look back in time to assess exposure status and health outcomes.

Cohort studies are useful for establishing causality between an exposure and an outcome because they allow researchers to observe the temporal relationship between the two. They can also provide information on the incidence of a disease or condition in different populations, which can be used to inform public health policy and interventions. However, cohort studies can be expensive and time-consuming to conduct, and they may be subject to bias if participants are not representative of the population or if there is loss to follow-up.

Sulfonylurea compounds are a group of medications used in the management of type 2 diabetes. They work by stimulating the release of insulin from the pancreas, thereby lowering blood glucose levels. These compounds bind to specific receptors on the beta cells of the pancreas, which triggers the release of insulin.

Examples of sulfonylurea compounds include glipizide, glyburide, and glimepiride. It's important to note that these medications can cause hypoglycemia (low blood sugar) if not properly monitored and dosed. They are often used in combination with other medications, such as metformin, to achieve optimal blood glucose control.

As with any medication, sulfonylurea compounds should be taken under the supervision of a healthcare provider, who can monitor their effectiveness and potential side effects.

Insulin-secreting cells, also known as beta cells, are a type of cell found in the pancreas. They are responsible for producing and releasing insulin, a hormone that regulates blood glucose levels by allowing cells in the body to take in glucose from the bloodstream. Insulin-secreting cells are clustered together in the pancreatic islets, along with other types of cells that produce other hormones such as glucagon and somatostatin. In people with diabetes, these cells may not function properly, leading to an impaired ability to regulate blood sugar levels.

Diabetes Insipidus is a medical condition characterized by the excretion of large amounts of dilute urine (polyuria) and increased thirst (polydipsia). It is caused by a deficiency in the hormone vasopressin (also known as antidiuretic hormone or ADH), which regulates the body's water balance.

In normal physiology, vasopressin is released from the posterior pituitary gland in response to an increase in osmolality of the blood or a decrease in blood volume. This causes the kidneys to retain water and concentrate the urine. In Diabetes Insipidus, there is either a lack of vasopressin production (central diabetes insipidus) or a decreased response to vasopressin by the kidneys (nephrogenic diabetes insipidus).

Central Diabetes Insipidus can be caused by damage to the hypothalamus or pituitary gland, such as from tumors, trauma, or surgery. Nephrogenic Diabetes Insipidus can be caused by genetic factors, kidney disease, or certain medications that interfere with the action of vasopressin on the kidneys.

Treatment for Diabetes Insipidus depends on the underlying cause. In central diabetes insipidus, desmopressin, a synthetic analogue of vasopressin, can be administered to replace the missing hormone. In nephrogenic diabetes insipidus, treatment may involve addressing the underlying kidney disease or adjusting medications that interfere with vasopressin action. It is important for individuals with Diabetes Insipidus to maintain adequate hydration and monitor their fluid intake and urine output.

Glucose is a simple monosaccharide (or single sugar) that serves as the primary source of energy for living organisms. It's a fundamental molecule in biology, often referred to as "dextrose" or "grape sugar." Glucose has the molecular formula C6H12O6 and is vital to the functioning of cells, especially those in the brain and nervous system.

In the body, glucose is derived from the digestion of carbohydrates in food, and it's transported around the body via the bloodstream to cells where it can be used for energy. Cells convert glucose into a usable form through a process called cellular respiration, which involves a series of metabolic reactions that generate adenosine triphosphate (ATP)—the main currency of energy in cells.

Glucose is also stored in the liver and muscles as glycogen, a polysaccharide (multiple sugar) that can be broken down back into glucose when needed for energy between meals or during physical activity. Maintaining appropriate blood glucose levels is crucial for overall health, and imbalances can lead to conditions such as diabetes mellitus.

Metformin is a type of biguanide antihyperglycemic agent used primarily in the treatment of type 2 diabetes mellitus. It works by decreasing glucose production in the liver, reducing glucose absorption in the gut, and increasing insulin sensitivity in muscle and fat tissue. By lowering both basal and postprandial plasma glucose levels, metformin helps to control blood sugar levels and improve glycemic control. It is also used off-label for various other indications such as polycystic ovary syndrome (PCOS) and gestational diabetes. Common side effects include diarrhea, nausea, vomiting, and abdominal discomfort. Lactic acidosis is a rare but serious side effect that requires immediate medical attention.

In epidemiology, the incidence of a disease is defined as the number of new cases of that disease within a specific population over a certain period of time. It is typically expressed as a rate, with the number of new cases in the numerator and the size of the population at risk in the denominator. Incidence provides information about the risk of developing a disease during a given time period and can be used to compare disease rates between different populations or to monitor trends in disease occurrence over time.

Blood glucose self-monitoring is the regular measurement of blood glucose levels performed by individuals with diabetes to manage their condition. This process involves using a portable device, such as a glucometer or continuous glucose monitor (CGM), to measure the amount of glucose present in a small sample of blood, usually obtained through a fingerstick.

The primary purpose of self-monitoring is to help individuals with diabetes understand how various factors, such as food intake, physical activity, medication, and stress, affect their blood glucose levels. By tracking these patterns, they can make informed decisions about adjusting their diet, exercise, or medication regimens to maintain optimal glycemic control and reduce the risk of long-term complications associated with diabetes.

Self-monitoring is an essential component of diabetes self-management and education, enabling individuals to take an active role in their healthcare. Regular monitoring also allows healthcare professionals to assess a patient's adherence to their treatment plan and make necessary adjustments based on the data collected.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

C-peptide is a byproduct that is produced when the hormone insulin is generated in the body. Insulin is a hormone that helps regulate blood sugar levels, and it is produced in the pancreas by specialized cells called beta cells. When these cells produce insulin, they also generate C-peptide as a part of the same process.

C-peptide is often used as a marker to measure the body's insulin production. By measuring C-peptide levels in the blood, healthcare providers can get an idea of how much insulin the body is producing on its own. This can be helpful in diagnosing and monitoring conditions such as diabetes, which is characterized by impaired insulin production or function.

It's worth noting that C-peptide is not typically used as a treatment for any medical conditions. Instead, it is primarily used as a diagnostic tool to help healthcare providers better understand their patients' health status and make informed treatment decisions.

Albuminuria is a medical condition that refers to the presence of albumin in the urine. Albumin is a type of protein normally found in the blood, but not in the urine. When the kidneys are functioning properly, they prevent large proteins like albumin from passing through into the urine. However, when the kidneys are damaged or not working correctly, such as in nephrotic syndrome or other kidney diseases, small amounts of albumin can leak into the urine.

The amount of albumin in the urine is often measured in milligrams per liter (mg/L) or in a spot urine sample, as the albumin-to-creatinine ratio (ACR). A small amount of albumin in the urine is called microalbuminuria, while a larger amount is called macroalbuminuria or proteinuria. The presence of albuminuria can indicate kidney damage and may be a sign of underlying medical conditions such as diabetes or high blood pressure. It is important to monitor and manage albuminuria to prevent further kidney damage and potential complications.

Fasting is defined in medical terms as the abstinence from food or drink for a period of time. This practice is often recommended before certain medical tests or procedures, as it helps to ensure that the results are not affected by recent eating or drinking.

In some cases, fasting may also be used as a therapeutic intervention, such as in the management of seizures or other neurological conditions. Fasting can help to lower blood sugar and insulin levels, which can have a variety of health benefits. However, it is important to note that prolonged fasting can also have negative effects on the body, including malnutrition, dehydration, and electrolyte imbalances.

Fasting is also a spiritual practice in many religions, including Christianity, Islam, Buddhism, and Hinduism. In these contexts, fasting is often seen as a way to purify the mind and body, to focus on spiritual practices, or to express devotion or mourning.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

A biological marker, often referred to as a biomarker, is a measurable indicator that reflects the presence or severity of a disease state, or a response to a therapeutic intervention. Biomarkers can be found in various materials such as blood, tissues, or bodily fluids, and they can take many forms, including molecular, histologic, radiographic, or physiological measurements.

In the context of medical research and clinical practice, biomarkers are used for a variety of purposes, such as:

1. Diagnosis: Biomarkers can help diagnose a disease by indicating the presence or absence of a particular condition. For example, prostate-specific antigen (PSA) is a biomarker used to detect prostate cancer.
2. Monitoring: Biomarkers can be used to monitor the progression or regression of a disease over time. For instance, hemoglobin A1c (HbA1c) levels are monitored in diabetes patients to assess long-term blood glucose control.
3. Predicting: Biomarkers can help predict the likelihood of developing a particular disease or the risk of a negative outcome. For example, the presence of certain genetic mutations can indicate an increased risk for breast cancer.
4. Response to treatment: Biomarkers can be used to evaluate the effectiveness of a specific treatment by measuring changes in the biomarker levels before and after the intervention. This is particularly useful in personalized medicine, where treatments are tailored to individual patients based on their unique biomarker profiles.

It's important to note that for a biomarker to be considered clinically valid and useful, it must undergo rigorous validation through well-designed studies, including demonstrating sensitivity, specificity, reproducibility, and clinical relevance.

Glutamate decarboxylase (GAD) is an enzyme that plays a crucial role in the synthesis of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain. GABA is an inhibitory neurotransmitter that helps to balance the excitatory effects of glutamate, another neurotransmitter.

Glutamate decarboxylase catalyzes the conversion of glutamate to GABA by removing a carboxyl group from the glutamate molecule. This reaction occurs in two steps, with the enzyme first converting glutamate to glutamic acid semialdehyde and then converting that intermediate product to GABA.

There are two major isoforms of glutamate decarboxylase, GAD65 and GAD67, which differ in their molecular weight, subcellular localization, and function. GAD65 is primarily responsible for the synthesis of GABA in neuronal synapses, while GAD67 is responsible for the synthesis of GABA in the cell body and dendrites of neurons.

Glutamate decarboxylase is an important target for research in neurology and psychiatry because dysregulation of GABAergic neurotransmission has been implicated in a variety of neurological and psychiatric disorders, including epilepsy, anxiety, depression, and schizophrenia.

A cross-sectional study is a type of observational research design that examines the relationship between variables at one point in time. It provides a snapshot or a "cross-section" of the population at a particular moment, allowing researchers to estimate the prevalence of a disease or condition and identify potential risk factors or associations.

In a cross-sectional study, data is collected from a sample of participants at a single time point, and the variables of interest are measured simultaneously. This design can be used to investigate the association between exposure and outcome, but it cannot establish causality because it does not follow changes over time.

Cross-sectional studies can be conducted using various data collection methods, such as surveys, interviews, or medical examinations. They are often used in epidemiology to estimate the prevalence of a disease or condition in a population and to identify potential risk factors that may contribute to its development. However, because cross-sectional studies only provide a snapshot of the population at one point in time, they cannot account for changes over time or determine whether exposure preceded the outcome.

Therefore, while cross-sectional studies can be useful for generating hypotheses and identifying potential associations between variables, further research using other study designs, such as cohort or case-control studies, is necessary to establish causality and confirm any findings.

Risk assessment in the medical context refers to the process of identifying, evaluating, and prioritizing risks to patients, healthcare workers, or the community related to healthcare delivery. It involves determining the likelihood and potential impact of adverse events or hazards, such as infectious diseases, medication errors, or medical devices failures, and implementing measures to mitigate or manage those risks. The goal of risk assessment is to promote safe and high-quality care by identifying areas for improvement and taking action to minimize harm.

A diabetic diet is a meal plan that is designed to help manage blood sugar levels in individuals with diabetes. The main focus of this diet is to consume a balanced and varied diet with appropriate portion sizes, while controlling the intake of carbohydrates, which have the greatest impact on blood sugar levels. Here are some key components of a diabetic diet:

1. Carbohydrate counting: Monitoring the amount of carbohydrates consumed at each meal and snack is essential for maintaining stable blood sugar levels. Carbohydrates should be sourced from whole foods, such as fruits, vegetables, legumes, and whole grains, rather than refined or processed products.
2. Fiber-rich foods: Foods high in fiber, like fruits, vegetables, nuts, seeds, and whole grains, can help slow down the absorption of carbohydrates and minimize blood sugar spikes. Aim for at least 25 to 30 grams of fiber per day.
3. Lean protein sources: Choose lean protein sources such as chicken, turkey, fish, eggs, tofu, and low-fat dairy products. Limit red meat and processed meats, which can contribute to heart disease risk.
4. Healthy fats: Opt for monounsaturated and polyunsaturated fats found in foods like avocados, olive oil, nuts, seeds, and fatty fish. These healthy fats can help reduce inflammation and improve insulin sensitivity.
5. Portion control: Pay attention to serving sizes and avoid overeating, especially when consuming high-calorie or high-fat foods.
6. Regular meals: Eating regularly spaced meals throughout the day can help maintain stable blood sugar levels and prevent extreme highs and lows.
7. Limit added sugars: Reduce or eliminate added sugars in your diet, such as those found in sweets, desserts, sugary drinks, and processed foods.
8. Monitoring: Regularly monitor blood sugar levels before and after meals to understand how different foods affect your body and adjust your meal plan accordingly.
9. Personalization: A diabetic diet should be tailored to an individual's specific needs, preferences, and lifestyle. Consult with a registered dietitian or certified diabetes educator for personalized guidance.

Comorbidity is the presence of one or more additional health conditions or diseases alongside a primary illness or condition. These co-occurring health issues can have an impact on the treatment plan, prognosis, and overall healthcare management of an individual. Comorbidities often interact with each other and the primary condition, leading to more complex clinical situations and increased healthcare needs. It is essential for healthcare professionals to consider and address comorbidities to provide comprehensive care and improve patient outcomes.

"Age factors" refer to the effects, changes, or differences that age can have on various aspects of health, disease, and medical care. These factors can encompass a wide range of issues, including:

1. Physiological changes: As people age, their bodies undergo numerous physical changes that can affect how they respond to medications, illnesses, and medical procedures. For example, older adults may be more sensitive to certain drugs or have weaker immune systems, making them more susceptible to infections.
2. Chronic conditions: Age is a significant risk factor for many chronic diseases, such as heart disease, diabetes, cancer, and arthritis. As a result, age-related medical issues are common and can impact treatment decisions and outcomes.
3. Cognitive decline: Aging can also lead to cognitive changes, including memory loss and decreased decision-making abilities. These changes can affect a person's ability to understand and comply with medical instructions, leading to potential complications in their care.
4. Functional limitations: Older adults may experience physical limitations that impact their mobility, strength, and balance, increasing the risk of falls and other injuries. These limitations can also make it more challenging for them to perform daily activities, such as bathing, dressing, or cooking.
5. Social determinants: Age-related factors, such as social isolation, poverty, and lack of access to transportation, can impact a person's ability to obtain necessary medical care and affect their overall health outcomes.

Understanding age factors is critical for healthcare providers to deliver high-quality, patient-centered care that addresses the unique needs and challenges of older adults. By taking these factors into account, healthcare providers can develop personalized treatment plans that consider a person's age, physical condition, cognitive abilities, and social circumstances.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

Inbred NOD (Nonobese Diabetic) mice are a strain of laboratory mice that are genetically predisposed to develop autoimmune diabetes. This strain was originally developed in Japan and has been widely used as an animal model for studying type 1 diabetes and its complications.

NOD mice typically develop diabetes spontaneously at around 12-14 weeks of age, although the onset and severity of the disease can vary between individual mice. The disease is caused by a breakdown in immune tolerance, leading to an autoimmune attack on the insulin-producing beta cells of the pancreas.

Inbred NOD mice are highly valuable for research purposes because they exhibit many of the same genetic and immunological features as human patients with type 1 diabetes. By studying these mice, researchers can gain insights into the underlying mechanisms of the disease and develop new treatments and therapies.

Blood pressure is the force exerted by circulating blood on the walls of the blood vessels. It is measured in millimeters of mercury (mmHg) and is given as two figures:

1. Systolic pressure: This is the pressure when the heart pushes blood out into the arteries.
2. Diastolic pressure: This is the pressure when the heart rests between beats, allowing it to fill with blood.

Normal blood pressure for adults is typically around 120/80 mmHg, although this can vary slightly depending on age, sex, and other factors. High blood pressure (hypertension) is generally considered to be a reading of 130/80 mmHg or higher, while low blood pressure (hypotension) is usually defined as a reading below 90/60 mmHg. It's important to note that blood pressure can fluctuate throughout the day and may be affected by factors such as stress, physical activity, and medication use.

Metabolic syndrome, also known as Syndrome X, is a cluster of conditions that increase the risk of heart disease, stroke, and diabetes. It is not a single disease but a group of risk factors that often co-occur. According to the American Heart Association and the National Heart, Lung, and Blood Institute, a person has metabolic syndrome if they have any three of the following five conditions:

1. Abdominal obesity (waist circumference of 40 inches or more in men, and 35 inches or more in women)
2. Triglyceride level of 150 milligrams per deciliter of blood (mg/dL) or greater
3. HDL cholesterol level of less than 40 mg/dL in men or less than 50 mg/dL in women
4. Systolic blood pressure of 130 millimeters of mercury (mmHg) or greater, or diastolic blood pressure of 85 mmHg or greater
5. Fasting glucose level of 100 mg/dL or greater

Metabolic syndrome is thought to be caused by a combination of genetic and lifestyle factors, such as physical inactivity and a diet high in refined carbohydrates and unhealthy fats. Treatment typically involves making lifestyle changes, such as eating a healthy diet, getting regular exercise, and losing weight if necessary. In some cases, medication may also be needed to manage individual components of the syndrome, such as high blood pressure or high cholesterol.

Multivariate analysis is a statistical method used to examine the relationship between multiple independent variables and a dependent variable. It allows for the simultaneous examination of the effects of two or more independent variables on an outcome, while controlling for the effects of other variables in the model. This technique can be used to identify patterns, associations, and interactions among multiple variables, and is commonly used in medical research to understand complex health outcomes and disease processes. Examples of multivariate analysis methods include multiple regression, factor analysis, cluster analysis, and discriminant analysis.

I'm sorry for any confusion, but "Rats, Inbred BB" is not a widely recognized medical term or abbreviation in human or veterinary medicine. The term "inbred" is used in genetics to describe an organism that has resulted from many generations of mating between closely related individuals, which can lead to a higher incidence of homozygosity (the same allele inherited from both parents) and expression of recessive traits.

The "BB" strain could refer to a specific inbred rat strain, but without more context, it's difficult to provide a precise definition. The BB Wistar rat strain is sometimes used in research, and it has been used as a model for studying various medical conditions such as diabetes and hypertension.

If you are looking for information about a specific scientific study or medical condition related to an "Inbred BB" rat strain, I would be happy to help you if you could provide more context or details.

Alloxan is a chemical compound that is primarily used in laboratory research. Its medical definition is:

A toxic, crystalline substance, C6H4O6, derived from uric acid, and used experimentally to produce diabetes in animals by destroying their insulin-producing cells (beta cells) in the pancreas. Alloxan monohydrate is a white crystalline powder that is soluble in water and alcohol. It is used as a reagent in analytical chemistry and in photography.

In scientific research, alloxan is often used to induce diabetes in laboratory animals (like rats and mice) in order to study the disease and potential treatments. The compound is toxic to the insulin-producing beta cells in the pancreas, leading to a decrease in insulin production and an increase in blood glucose levels, similar to what occurs in type 1 diabetes in humans. However, it's important to note that alloxan-induced diabetes does not perfectly mimic the human form of the disease, and results from such studies may not always translate directly to human treatments.

Thiazolidinediones are a class of medications used to treat type 2 diabetes. They work by increasing the body's sensitivity to insulin, which helps to control blood sugar levels. These drugs bind to peroxisome proliferator-activated receptors (PPARs), specifically PPAR-gamma, and modulate gene expression related to glucose metabolism and lipid metabolism.

Examples of thiazolidinediones include pioglitazone and rosiglitazone. Common side effects of these medications include weight gain, fluid retention, and an increased risk of bone fractures. They have also been associated with an increased risk of heart failure and bladder cancer, which has led to restrictions or withdrawal of some thiazolidinediones in various countries.

It is important to note that thiazolidinediones should be used under the close supervision of a healthcare provider and in conjunction with lifestyle modifications such as diet and exercise.

I'm sorry for any confusion, but "United States" is a geopolitical entity, specifically the name of the country consisting of 50 states, and it is not a medical term or concept. Therefore, I can't provide a medical definition for it. If you have any questions related to health, medicine, or biology, I would be happy to try to help answer those!

"Sex factors" is a term used in medicine and epidemiology to refer to the differences in disease incidence, prevalence, or response to treatment that are observed between males and females. These differences can be attributed to biological differences such as genetics, hormones, and anatomy, as well as social and cultural factors related to gender.

For example, some conditions such as autoimmune diseases, depression, and osteoporosis are more common in women, while others such as cardiovascular disease and certain types of cancer are more prevalent in men. Additionally, sex differences have been observed in the effectiveness and side effects of various medications and treatments.

It is important to consider sex factors in medical research and clinical practice to ensure that patients receive appropriate and effective care.

Reference values, also known as reference ranges or reference intervals, are the set of values that are considered normal or typical for a particular population or group of people. These values are often used in laboratory tests to help interpret test results and determine whether a patient's value falls within the expected range.

The process of establishing reference values typically involves measuring a particular biomarker or parameter in a large, healthy population and then calculating the mean and standard deviation of the measurements. Based on these statistics, a range is established that includes a certain percentage of the population (often 95%) and excludes extreme outliers.

It's important to note that reference values can vary depending on factors such as age, sex, race, and other demographic characteristics. Therefore, it's essential to use reference values that are specific to the relevant population when interpreting laboratory test results. Additionally, reference values may change over time due to advances in measurement technology or changes in the population being studied.

An Insulin Infusion System, also known as an insulin pump, is a medical device designed to deliver insulin in a continuous and controlled manner. It consists of a small computerized device that is worn outside the body, connected to a thin tube called a cannula which is inserted under the skin using a needle. The cannula is typically changed every 2-3 days.

The system allows for the programming of basal rates (background insulin), as well as bolus doses (additional insulin given at mealtimes or to correct high blood glucose levels). The user has the ability to customize these settings based on their individual needs, which can be particularly useful for people with type 1 diabetes who require multiple daily injections of insulin.

Insulin infusion systems are designed to mimic the normal physiological release of insulin from the pancreas more closely than traditional injection methods, and they have been shown to improve glycemic control and quality of life for some people with diabetes. However, they also require a significant amount of user education and training to ensure safe and effective use.

Body weight is the measure of the force exerted on a scale or balance by an object's mass, most commonly expressed in units such as pounds (lb) or kilograms (kg). In the context of medical definitions, body weight typically refers to an individual's total weight, which includes their skeletal muscle, fat, organs, and bodily fluids.

Healthcare professionals often use body weight as a basic indicator of overall health status, as it can provide insights into various aspects of a person's health, such as nutritional status, metabolic function, and risk factors for certain diseases. For example, being significantly underweight or overweight can increase the risk of developing conditions like malnutrition, diabetes, heart disease, and certain types of cancer.

It is important to note that body weight alone may not provide a complete picture of an individual's health, as it does not account for factors such as muscle mass, bone density, or body composition. Therefore, healthcare professionals often use additional measures, such as body mass index (BMI), waist circumference, and blood tests, to assess overall health status more comprehensively.

Fructosamine is a glycated protein that is formed when glucose binds to proteins in the bloodstream. It is used as an indicator of average blood glucose levels over the previous 2-3 weeks, and can be measured through a blood test. Fructosamine results are not affected by short-term changes in blood sugar levels or acute illnesses, making it useful for monitoring long-term glycemic control in people with diabetes.

The fructosamine test measures the level of glycated proteins in the blood, specifically those that have bound to serum albumin. The test results are reported as micromoles per liter (µmol/L) or millimoles per liter (mmol/L). Higher levels of fructosamine indicate poorer glucose control and an increased risk for diabetes complications, while lower levels suggest better glycemic control.

It's important to note that the fructosamine test is not a replacement for hemoglobin A1c (HbA1c) testing, which measures average blood glucose levels over the previous 2-3 months. Instead, it can be used as an additional tool in managing diabetes and assessing glycemic control.

Logistic models, specifically logistic regression models, are a type of statistical analysis used in medical and epidemiological research to identify the relationship between the risk of a certain health outcome or disease (dependent variable) and one or more independent variables, such as demographic factors, exposure variables, or other clinical measurements.

In contrast to linear regression models, logistic regression models are used when the dependent variable is binary or dichotomous in nature, meaning it can only take on two values, such as "disease present" or "disease absent." The model uses a logistic function to estimate the probability of the outcome based on the independent variables.

Logistic regression models are useful for identifying risk factors and estimating the strength of associations between exposures and health outcomes, adjusting for potential confounders, and predicting the probability of an outcome given certain values of the independent variables. They can also be used to develop clinical prediction rules or scores that can aid in decision-making and patient care.

Lipids are a broad group of organic compounds that are insoluble in water but soluble in nonpolar organic solvents. They include fats, waxes, sterols, fat-soluble vitamins (such as vitamins A, D, E, and K), monoglycerides, diglycerides, triglycerides, and phospholipids. Lipids serve many important functions in the body, including energy storage, acting as structural components of cell membranes, and serving as signaling molecules. High levels of certain lipids, particularly cholesterol and triglycerides, in the blood are associated with an increased risk of cardiovascular disease.

Dipeptidyl-Peptidase IV (DPP-4) inhibitors are a class of medications used to treat type 2 diabetes. They work by increasing the levels of incretin hormones, such as glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP), which help regulate blood sugar levels in the body.

Incretin hormones are released from the gut in response to food intake and promote insulin secretion, suppress glucagon secretion, slow down gastric emptying, and reduce appetite. However, these hormones are rapidly degraded by the enzyme DPP-4, which reduces their effectiveness.

DPP-4 inhibitors block the action of this enzyme, thereby increasing the levels of incretin hormones in the body and enhancing their effects on blood sugar control. Some examples of DPP-4 inhibitors include sitagliptin, saxagliptin, linagliptin, and alogliptin.

These medications are usually taken orally once or twice a day and are often used in combination with other diabetes medications, such as metformin or sulfonylureas, to achieve better blood sugar control. Common side effects of DPP-4 inhibitors include upper respiratory tract infections, headache, and nasopharyngitis (inflammation of the throat and nasal passages).

I'm sorry for any confusion, but "Japan" is not a medical term. Japan is the name of a country, officially known as Nippon-koku or Nihon-koku in Japanese, and is located in East Asia. It is an island nation in the Pacific Ocean with a population of about 126 million people.

If you have any medical questions or terms that you would like me to define, please let me know!

Triglycerides are the most common type of fat in the body, and they're found in the food we eat. They're carried in the bloodstream to provide energy to the cells in our body. High levels of triglycerides in the blood can increase the risk of heart disease, especially in combination with other risk factors such as high LDL (bad) cholesterol, low HDL (good) cholesterol, and high blood pressure.

It's important to note that while triglycerides are a type of fat, they should not be confused with cholesterol, which is a waxy substance found in the cells of our body. Both triglycerides and cholesterol are important for maintaining good health, but high levels of either can increase the risk of heart disease.

Triglyceride levels are measured through a blood test called a lipid panel or lipid profile. A normal triglyceride level is less than 150 mg/dL. Borderline-high levels range from 150 to 199 mg/dL, high levels range from 200 to 499 mg/dL, and very high levels are 500 mg/dL or higher.

Elevated triglycerides can be caused by various factors such as obesity, physical inactivity, excessive alcohol consumption, smoking, and certain medical conditions like diabetes, hypothyroidism, and kidney disease. Medications such as beta-blockers, steroids, and diuretics can also raise triglyceride levels.

Lifestyle changes such as losing weight, exercising regularly, eating a healthy diet low in saturated and trans fats, avoiding excessive alcohol consumption, and quitting smoking can help lower triglyceride levels. In some cases, medication may be necessary to reduce triglycerides to recommended levels.

Coronary artery disease (CAD) is a medical condition in which the coronary arteries, which supply oxygen-rich blood to the heart muscle, become narrowed or blocked due to the buildup of cholesterol, fatty deposits, and other substances, known as plaque. Over time, this buildup can cause the arteries to harden and narrow (a process called atherosclerosis), reducing blood flow to the heart muscle.

The reduction in blood flow can lead to various symptoms and complications, including:

1. Angina (chest pain or discomfort) - This occurs when the heart muscle doesn't receive enough oxygen-rich blood, causing pain, pressure, or discomfort in the chest, arms, neck, jaw, or back.
2. Shortness of breath - When the heart isn't receiving adequate blood flow, it can't pump blood efficiently to meet the body's demands, leading to shortness of breath during physical activities or at rest.
3. Heart attack - If a piece of plaque ruptures or breaks off in a coronary artery, a blood clot can form and block the artery, causing a heart attack (myocardial infarction). This can damage or destroy part of the heart muscle.
4. Heart failure - Chronic reduced blood flow to the heart muscle can weaken it over time, leading to heart failure, a condition in which the heart can't pump blood efficiently to meet the body's needs.
5. Arrhythmias - Reduced blood flow and damage to the heart muscle can lead to abnormal heart rhythms (arrhythmias), which can be life-threatening if not treated promptly.

Coronary artery disease is typically diagnosed through a combination of medical history, physical examination, and diagnostic tests such as electrocardiograms (ECGs), stress testing, cardiac catheterization, and imaging studies like coronary computed tomography angiography (CCTA). Treatment options for CAD include lifestyle modifications, medications, medical procedures, and surgery.

The term "diabetic foot" refers to a condition that affects the feet of people with diabetes, particularly when the disease is not well-controlled. It is characterized by a combination of nerve damage (neuropathy) and poor circulation (peripheral artery disease) in the feet and lower legs.

Neuropathy can cause numbness, tingling, or pain in the feet, making it difficult for people with diabetes to feel injuries, cuts, blisters, or other foot problems. Poor circulation makes it harder for wounds to heal and increases the risk of infection.

Diabetic foot ulcers are a common complication of diabetic neuropathy and can lead to serious infections, hospitalization, and even amputation if not treated promptly and effectively. Preventive care, including regular foot exams, proper footwear, and good blood glucose control, is essential for people with diabetes to prevent or manage diabetic foot problems.

The odds ratio (OR) is a statistical measure used in epidemiology and research to estimate the association between an exposure and an outcome. It represents the odds that an event will occur in one group versus the odds that it will occur in another group, assuming that all other factors are held constant.

In medical research, the odds ratio is often used to quantify the strength of the relationship between a risk factor (exposure) and a disease outcome. An OR of 1 indicates no association between the exposure and the outcome, while an OR greater than 1 suggests that there is a positive association between the two. Conversely, an OR less than 1 implies a negative association.

It's important to note that the odds ratio is not the same as the relative risk (RR), which compares the incidence rates of an outcome in two groups. While the OR can approximate the RR when the outcome is rare, they are not interchangeable and can lead to different conclusions about the association between an exposure and an outcome.

Genetic predisposition to disease refers to an increased susceptibility or vulnerability to develop a particular illness or condition due to inheriting specific genetic variations or mutations from one's parents. These genetic factors can make it more likely for an individual to develop a certain disease, but it does not guarantee that the person will definitely get the disease. Environmental factors, lifestyle choices, and interactions between genes also play crucial roles in determining if a genetically predisposed person will actually develop the disease. It is essential to understand that having a genetic predisposition only implies a higher risk, not an inevitable outcome.

Regression analysis is a statistical technique used in medicine, as well as in other fields, to examine the relationship between one or more independent variables (predictors) and a dependent variable (outcome). It allows for the estimation of the average change in the outcome variable associated with a one-unit change in an independent variable, while controlling for the effects of other independent variables. This technique is often used to identify risk factors for diseases or to evaluate the effectiveness of medical interventions. In medical research, regression analysis can be used to adjust for potential confounding variables and to quantify the relationship between exposures and health outcomes. It can also be used in predictive modeling to estimate the probability of a particular outcome based on multiple predictors.

The pancreas is a glandular organ located in the abdomen, posterior to the stomach. It has both exocrine and endocrine functions. The exocrine portion of the pancreas consists of acinar cells that produce and secrete digestive enzymes into the duodenum via the pancreatic duct. These enzymes help in the breakdown of proteins, carbohydrates, and fats in food.

The endocrine portion of the pancreas consists of clusters of cells called islets of Langerhans, which include alpha, beta, delta, and F cells. These cells produce and secrete hormones directly into the bloodstream, including insulin, glucagon, somatostatin, and pancreatic polypeptide. Insulin and glucagon are critical regulators of blood sugar levels, with insulin promoting glucose uptake and storage in tissues and glucagon stimulating glycogenolysis and gluconeogenesis to raise blood glucose when it is low.

Hyperlipidemias are a group of disorders characterized by an excess of lipids (fats) or lipoproteins in the blood. These include elevated levels of cholesterol, triglycerides, or both. Hyperlipidemias can be inherited (primary) or caused by other medical conditions (secondary). They are a significant risk factor for developing cardiovascular diseases, such as atherosclerosis and coronary artery disease.

There are two main types of lipids that are commonly measured in the blood: low-density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol, and high-density lipoprotein (HDL) cholesterol, known as "good" cholesterol. High levels of LDL cholesterol can lead to the formation of plaques in the arteries, which can narrow or block them and increase the risk of heart attack or stroke. On the other hand, high levels of HDL cholesterol are protective because they help remove LDL cholesterol from the bloodstream.

Triglycerides are another type of lipid that can be measured in the blood. Elevated triglyceride levels can also contribute to the development of cardiovascular disease, particularly when combined with high LDL cholesterol and low HDL cholesterol levels.

Hyperlipidemias are typically diagnosed through a blood test that measures the levels of various lipids and lipoproteins in the blood. Treatment may include lifestyle changes, such as following a healthy diet, getting regular exercise, losing weight, and quitting smoking, as well as medication to lower lipid levels if necessary.

Dyslipidemia is a condition characterized by an abnormal amount of cholesterol and/or triglycerides in the blood. It can be caused by genetic factors, lifestyle habits such as poor diet and lack of exercise, or other medical conditions such as diabetes or hypothyroidism.

There are several types of dyslipidemias, including:

1. Hypercholesterolemia: This is an excess of low-density lipoprotein (LDL) cholesterol, also known as "bad" cholesterol, in the blood. High levels of LDL cholesterol can lead to the formation of plaque in the arteries, increasing the risk of heart disease and stroke.
2. Hypertriglyceridemia: This is an excess of triglycerides, a type of fat found in the blood, which can also contribute to the development of plaque in the arteries.
3. Mixed dyslipidemia: This is a combination of high LDL cholesterol and high triglycerides.
4. Low high-density lipoprotein (HDL) cholesterol: HDL cholesterol, also known as "good" cholesterol, helps remove LDL cholesterol from the blood. Low levels of HDL cholesterol can increase the risk of heart disease and stroke.

Dyslipidemias often do not cause any symptoms but can be detected through a blood test that measures cholesterol and triglyceride levels. Treatment typically involves lifestyle changes such as eating a healthy diet, getting regular exercise, and quitting smoking. In some cases, medication may also be necessary to lower cholesterol or triglyceride levels.

Glucagon-like peptide 1 (GLP-1) is a hormone that is secreted by the intestines in response to food intake. It plays a crucial role in regulating blood sugar levels through several mechanisms, including stimulation of insulin secretion from the pancreas, inhibition of glucagon release, slowing gastric emptying, and promoting satiety. GLP-1 is an important target for the treatment of type 2 diabetes due to its insulin-secretory and glucose-lowering effects. In addition, GLP-1 receptor agonists are used in the management of obesity due to their ability to promote weight loss by reducing appetite and increasing feelings of fullness.

The Predictive Value of Tests, specifically the Positive Predictive Value (PPV) and Negative Predictive Value (NPV), are measures used in diagnostic tests to determine the probability that a positive or negative test result is correct.

Positive Predictive Value (PPV) is the proportion of patients with a positive test result who actually have the disease. It is calculated as the number of true positives divided by the total number of positive results (true positives + false positives). A higher PPV indicates that a positive test result is more likely to be a true positive, and therefore the disease is more likely to be present.

Negative Predictive Value (NPV) is the proportion of patients with a negative test result who do not have the disease. It is calculated as the number of true negatives divided by the total number of negative results (true negatives + false negatives). A higher NPV indicates that a negative test result is more likely to be a true negative, and therefore the disease is less likely to be present.

The predictive value of tests depends on the prevalence of the disease in the population being tested, as well as the sensitivity and specificity of the test. A test with high sensitivity and specificity will generally have higher predictive values than a test with low sensitivity and specificity. However, even a highly sensitive and specific test can have low predictive values if the prevalence of the disease is low in the population being tested.

Proportional hazards models are a type of statistical analysis used in medical research to investigate the relationship between covariates (predictor variables) and survival times. The most common application of proportional hazards models is in the Cox regression model, which is named after its developer, Sir David Cox.

In a proportional hazards model, the hazard rate or risk of an event occurring at a given time is assumed to be proportional to the hazard rate of a reference group, after adjusting for the covariates. This means that the ratio of the hazard rates between any two individuals remains constant over time, regardless of their survival times.

Mathematically, the hazard function h(t) at time t for an individual with a set of covariates X can be expressed as:

h(t|X) = h0(t) \* exp(β1X1 + β2X2 + ... + βpXp)

where h0(t) is the baseline hazard function, X1, X2, ..., Xp are the covariates, and β1, β2, ..., βp are the regression coefficients that represent the effect of each covariate on the hazard rate.

The assumption of proportionality is crucial in the interpretation of the results from a Cox regression model. If the assumption is violated, then the estimated regression coefficients may be biased and misleading. Therefore, it is important to test for the proportional hazards assumption before interpreting the results of a Cox regression analysis.

Glycosuria is a medical term that refers to the presence of glucose in the urine. Under normal circumstances, the kidneys are able to reabsorb all of the filtered glucose back into the bloodstream. However, when the blood glucose levels become excessively high, such as in uncontrolled diabetes mellitus, the kidneys may not be able to reabsorb all of the glucose, and some of it will spill over into the urine.

Glycosuria can also occur in other conditions that affect glucose metabolism or renal function, such as impaired kidney function, certain medications, pregnancy, and rare genetic disorders. It is important to note that glycosuria alone does not necessarily indicate diabetes, but it may be a sign of an underlying medical condition that requires further evaluation by a healthcare professional.

Self care is a health practice that involves individuals taking responsibility for their own health and well-being by actively seeking out and participating in activities and behaviors that promote healthy living, prevent illness and disease, and manage existing medical conditions. Self care includes a wide range of activities such as:

* Following a healthy diet and exercise routine
* Getting adequate sleep and rest
* Managing stress through relaxation techniques or mindfulness practices
* Practicing good hygiene and grooming habits
* Seeking preventive care through regular check-ups and screenings
* Taking prescribed medications as directed by a healthcare provider
* Monitoring symptoms and seeking medical attention when necessary

Self care is an important part of overall health and wellness, and can help individuals maintain their physical, emotional, and mental health. It is also an essential component of chronic disease management, helping people with ongoing medical conditions to manage their symptoms and improve their quality of life.

The term "Asian Continental Ancestry Group" is a medical/ethnic classification used to describe a person's genetic background and ancestry. According to this categorization, individuals with origins in the Asian continent are grouped together. This includes populations from regions such as East Asia (e.g., China, Japan, Korea), South Asia (e.g., India, Pakistan, Bangladesh), Southeast Asia (e.g., Philippines, Indonesia, Thailand), and Central Asia (e.g., Kazakhstan, Uzbekistan, Tajikistan). It is important to note that this broad categorization may not fully capture the genetic diversity within these regions or accurately reflect an individual's specific ancestral origins.

Chronic kidney failure, also known as chronic kidney disease (CKD) stage 5 or end-stage renal disease (ESRD), is a permanent loss of kidney function that occurs gradually over a period of months to years. It is defined as a glomerular filtration rate (GFR) of less than 15 ml/min, which means the kidneys are filtering waste and excess fluids at less than 15% of their normal capacity.

CKD can be caused by various underlying conditions such as diabetes, hypertension, glomerulonephritis, polycystic kidney disease, and recurrent kidney infections. Over time, the damage to the kidneys can lead to a buildup of waste products and fluids in the body, which can cause a range of symptoms including fatigue, weakness, shortness of breath, nausea, vomiting, and confusion.

Treatment for chronic kidney failure typically involves managing the underlying condition, making lifestyle changes such as following a healthy diet, and receiving supportive care such as dialysis or a kidney transplant to replace lost kidney function.

Autoantibodies are defined as antibodies that are produced by the immune system and target the body's own cells, tissues, or organs. These antibodies mistakenly identify certain proteins or molecules in the body as foreign invaders and attack them, leading to an autoimmune response. Autoantibodies can be found in various autoimmune diseases such as rheumatoid arthritis, lupus, and thyroiditis. The presence of autoantibodies can also be used as a diagnostic marker for certain conditions.

The glucose clamp technique is a method used in medical research, particularly in the study of glucose metabolism and insulin action. It's a controlled procedure that aims to maintain a steady state of plasma glucose concentration in an individual for a specific period.

In this technique, a continuous infusion of glucose is administered intravenously at a variable rate to balance the amount of glucose being removed from the circulation (for example, by insulin-stimulated uptake in muscle and fat tissue). This creates a "clamp" of stable plasma glucose concentration.

The rate of glucose infusion is adjusted according to frequent measurements of blood glucose levels, typically every 5 to 10 minutes, to keep the glucose level constant. The glucose clamp technique allows researchers to study how different factors, such as various doses of insulin or other drugs, affect glucose metabolism under standardized conditions.

There are two primary types of glucose clamps: the hyperglycemic clamp and the euglycemic clamp. The former aims to raise and maintain plasma glucose at a higher-than-normal level, while the latter maintains plasma glucose at a normal, euglycemic level.

The Chi-square distribution is a continuous probability distribution that is often used in statistical hypothesis testing. It is the distribution of a sum of squares of k independent standard normal random variables. The resulting quantity follows a chi-square distribution with k degrees of freedom, denoted as χ²(k).

The probability density function (pdf) of the Chi-square distribution with k degrees of freedom is given by:

f(x; k) = (1/ (2^(k/2) * Γ(k/2))) \* x^((k/2)-1) \* e^(-x/2), for x > 0 and 0, otherwise.

Where Γ(k/2) is the gamma function evaluated at k/2. The mean and variance of a Chi-square distribution with k degrees of freedom are k and 2k, respectively.

The Chi-square distribution has various applications in statistical inference, including testing goodness-of-fit, homogeneity of variances, and independence in contingency tables.

I'm sorry for any confusion, but "life style" is not a term that has a specific medical definition. It generally refers to the way an individual or group lives, including their habits, behaviors, and preferences in areas such as diet, exercise, recreation, and stress management. Some lifestyle factors can have a significant impact on health outcomes and risk for certain diseases. However, it is not a medical term with a specific clinical meaning.

Genotype, in genetics, refers to the complete heritable genetic makeup of an individual organism, including all of its genes. It is the set of instructions contained in an organism's DNA for the development and function of that organism. The genotype is the basis for an individual's inherited traits, and it can be contrasted with an individual's phenotype, which refers to the observable physical or biochemical characteristics of an organism that result from the expression of its genes in combination with environmental influences.

It is important to note that an individual's genotype is not necessarily identical to their genetic sequence. Some genes have multiple forms called alleles, and an individual may inherit different alleles for a given gene from each parent. The combination of alleles that an individual inherits for a particular gene is known as their genotype for that gene.

Understanding an individual's genotype can provide important information about their susceptibility to certain diseases, their response to drugs and other treatments, and their risk of passing on inherited genetic disorders to their offspring.

Islet Amyloid Polypeptide (IAPP), also known as amylin, is a 37-amino acid peptide co-secreted with insulin from pancreatic beta-cells in response to meals. It plays crucial roles in regulating glucose homeostasis by suppressing glucagon secretion, slowing gastric emptying, and promoting satiety. In type 2 diabetes, IAPP can form amyloid fibrils, which deposit in pancreatic islets, contributing to beta-cell dysfunction and death. This contributes to the progressive nature of type 2 diabetes.

The postprandial period is the time frame following a meal, during which the body is engaged in the process of digestion, absorption, and assimilation of nutrients. In a medical context, this term generally refers to the few hours after eating when the body is responding to the ingested food, particularly in terms of changes in metabolism and insulin levels.

The postprandial period can be of specific interest in the study and management of conditions such as diabetes, where understanding how the body handles glucose during this time can inform treatment decisions and strategies for maintaining healthy blood sugar levels.

A questionnaire in the medical context is a standardized, systematic, and structured tool used to gather information from individuals regarding their symptoms, medical history, lifestyle, or other health-related factors. It typically consists of a series of written questions that can be either self-administered or administered by an interviewer. Questionnaires are widely used in various areas of healthcare, including clinical research, epidemiological studies, patient care, and health services evaluation to collect data that can inform diagnosis, treatment planning, and population health management. They provide a consistent and organized method for obtaining information from large groups or individual patients, helping to ensure accurate and comprehensive data collection while minimizing bias and variability in the information gathered.

"Native Americans" is the preferred term for the indigenous peoples of the continental United States, including those from Alaska and Hawaii. The term "Indians" is often used to refer to this group, but it can be seen as misleading or inaccurate since it implies a connection to India rather than recognition of their unique cultures and histories. However, some Native Americans prefer to use the term "Indian" to describe themselves.

It's important to note that there is no single medical definition for this group, as they are not a homogeneous population. Instead, they consist of hundreds of distinct tribes with diverse cultures, languages, and traditions. Each tribe may have its own unique genetic makeup, which can influence health outcomes and responses to medical treatments.

Therefore, when discussing medical issues related to Native Americans, it's essential to consider the specific tribal affiliations and cultural factors that may impact their health status and healthcare needs.

Disease progression is the worsening or advancement of a medical condition over time. It refers to the natural course of a disease, including its development, the severity of symptoms and complications, and the impact on the patient's overall health and quality of life. Understanding disease progression is important for developing appropriate treatment plans, monitoring response to therapy, and predicting outcomes.

The rate of disease progression can vary widely depending on the type of medical condition, individual patient factors, and the effectiveness of treatment. Some diseases may progress rapidly over a short period of time, while others may progress more slowly over many years. In some cases, disease progression may be slowed or even halted with appropriate medical interventions, while in other cases, the progression may be inevitable and irreversible.

In clinical practice, healthcare providers closely monitor disease progression through regular assessments, imaging studies, and laboratory tests. This information is used to guide treatment decisions and adjust care plans as needed to optimize patient outcomes and improve quality of life.

Coronary artery disease, often simply referred to as coronary disease, is a condition in which the blood vessels that supply oxygen-rich blood to the heart become narrowed or blocked due to the buildup of fatty deposits called plaques. This can lead to chest pain (angina), shortness of breath, or in severe cases, a heart attack.

The medical definition of coronary artery disease is:

A condition characterized by the accumulation of atheromatous plaques in the walls of the coronary arteries, leading to decreased blood flow and oxygen supply to the myocardium (heart muscle). This can result in symptoms such as angina pectoris, shortness of breath, or arrhythmias, and may ultimately lead to myocardial infarction (heart attack) or heart failure.

Risk factors for coronary artery disease include age, smoking, high blood pressure, high cholesterol, diabetes, obesity, physical inactivity, and a family history of the condition. Lifestyle changes such as quitting smoking, exercising regularly, eating a healthy diet, and managing stress can help reduce the risk of developing coronary artery disease. Medical treatments may include medications to control blood pressure, cholesterol levels, or irregular heart rhythms, as well as procedures such as angioplasty or bypass surgery to improve blood flow to the heart.

Islets of Langerhans transplantation is a surgical procedure that involves the transplantation of isolated islets from a deceased donor's pancreas into another person with type 1 diabetes. The islets of Langerhans are clusters of cells within the pancreas that produce hormones, including insulin, which regulates blood sugar levels.

In type 1 diabetes, the body's immune system mistakenly attacks and destroys these insulin-producing cells, leading to high blood sugar levels. Islet transplantation aims to replace the damaged islets with healthy ones from a donor, allowing the recipient's body to produce and regulate its own insulin again.

The procedure involves extracting the islets from the donor pancreas and infusing them into the recipient's liver through a small incision in the abdomen. Once inside the liver, the islets can sense glucose levels in the bloodstream and release insulin as needed to maintain normal blood sugar levels.

Islet transplantation has shown promising results in improving blood sugar control and reducing the risk of severe hypoglycemia (low blood sugar) in people with type 1 diabetes. However, it requires long-term immunosuppressive therapy to prevent rejection of the transplanted islets, which can have side effects and increase the risk of infections.

In the context of medicine, risk is the probability or likelihood of an adverse health effect or the occurrence of a negative event related to treatment or exposure to certain hazards. It is usually expressed as a ratio or percentage and can be influenced by various factors such as age, gender, lifestyle, genetics, and environmental conditions. Risk assessment involves identifying, quantifying, and prioritizing risks to make informed decisions about prevention, mitigation, or treatment strategies.

Disease management is a proactive, planned approach to identify and manage patients with chronic medical conditions. It involves a systematic and coordinated method of delivering care to patients with the goal of improving clinical outcomes, enhancing quality of life, and reducing healthcare costs. This approach typically includes elements such as evidence-based care guidelines, patient education, self-management support, regular monitoring and follow-up, and collaboration between healthcare providers and specialists.

The objective of disease management is to improve the overall health and well-being of patients with chronic conditions by providing them with the necessary tools, resources, and support to effectively manage their condition and prevent complications. By implementing a comprehensive and coordinated approach to care, disease management can help reduce hospitalizations, emergency department visits, and other costly healthcare services while improving patient satisfaction and overall health outcomes.

Proinsulin is the precursor protein to insulin, produced in the beta cells of the pancreas. It has a molecular weight of around 9,000 daltons and is composed of three distinct regions: the A-chain, the B-chain, and the C-peptide. The A-chain and B-chain are linked together by disulfide bonds and will eventually become the insulin molecule after a series of enzymatic cleavages. The C-peptide is removed during this process and is released into the bloodstream in equimolar amounts to insulin. Proinsulin levels can be measured in the blood and are sometimes used as a marker for beta cell function in certain clinical settings, such as diagnosing or monitoring insulinoma (a tumor of the pancreas that produces insulin) or assessing the risk of diabetes-related complications.

Analysis of Variance (ANOVA) is a statistical technique used to compare the means of two or more groups and determine whether there are any significant differences between them. It is a way to analyze the variance in a dataset to determine whether the variability between groups is greater than the variability within groups, which can indicate that the groups are significantly different from one another.

ANOVA is based on the concept of partitioning the total variance in a dataset into two components: variance due to differences between group means (also known as "between-group variance") and variance due to differences within each group (also known as "within-group variance"). By comparing these two sources of variance, ANOVA can help researchers determine whether any observed differences between groups are statistically significant, or whether they could have occurred by chance.

ANOVA is a widely used technique in many areas of research, including biology, psychology, engineering, and business. It is often used to compare the means of two or more experimental groups, such as a treatment group and a control group, to determine whether the treatment had a significant effect. ANOVA can also be used to compare the means of different populations or subgroups within a population, to identify any differences that may exist between them.

Glucagon is a hormone produced by the alpha cells of the pancreas. Its main function is to regulate glucose levels in the blood by stimulating the liver to convert stored glycogen into glucose, which can then be released into the bloodstream. This process helps to raise blood sugar levels when they are too low, such as during hypoglycemia.

Glucagon is a 29-amino acid polypeptide that is derived from the preproglucagon protein. It works by binding to glucagon receptors on liver cells, which triggers a series of intracellular signaling events that lead to the activation of enzymes involved in glycogen breakdown.

In addition to its role in glucose regulation, glucagon has also been shown to have other physiological effects, such as promoting lipolysis (the breakdown of fat) and inhibiting gastric acid secretion. Glucagon is often used clinically in the treatment of hypoglycemia, as well as in diagnostic tests to assess pancreatic function.

Wolfram Syndrome is a rare, progressive, genetic disorder that affects multiple organ systems, particularly the eyes, brain, endocrine system, and hearing. It is characterized by the combination of several features including diabetes insipidus (DI), diabetes mellitus (DM), optic nerve atrophy, and various neurological symptoms. The onset of this syndrome typically occurs in childhood.

The two major types of Wolfram Syndrome are WFS1 and WFS2, with WFS1 being the most common form. They are caused by mutations in different genes (WFS1 and CISD2 respectively), both of which play a role in maintaining the health of cells in the body, particularly those in the pancreas, eyes, and ears.

The symptoms of Wolfram Syndrome can vary widely among affected individuals, but often include:
- Diabetes insipidus (DI): This is characterized by excessive thirst and urination due to problems with the body's regulation of fluids.
- Diabetes mellitus (DM): This type of diabetes results from issues with insulin production or usage, leading to high blood sugar levels.
- Optic nerve atrophy: This can cause vision loss, typically starting in early childhood and progressing over time.
- Neurological symptoms: These may include hearing loss, problems with balance and coordination, difficulty swallowing, and neuropsychiatric issues such as depression and anxiety.

Currently, there is no cure for Wolfram Syndrome, and treatment primarily focuses on managing the individual symptoms of the disorder.

"Sex distribution" is a term used to describe the number of males and females in a study population or sample. It can be presented as a simple count, a percentage, or a ratio. This information is often used in research to identify any differences in health outcomes, disease prevalence, or response to treatment between males and females. Additionally, understanding sex distribution can help researchers ensure that their studies are representative of the general population and can inform the design of future studies.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.

Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.

It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.

Adiponectin is a hormone that is produced and secreted by adipose tissue, which is another name for body fat. This hormone plays an important role in regulating metabolism and energy homeostasis. It helps to regulate glucose levels, break down fatty acids, and has anti-inflammatory effects.

Adiponectin is unique because it is exclusively produced by adipose tissue, and its levels are inversely related to body fat mass. This means that lean individuals tend to have higher levels of adiponectin than obese individuals. Low levels of adiponectin have been associated with an increased risk of developing various metabolic disorders, such as insulin resistance, type 2 diabetes, and cardiovascular disease.

Overall, adiponectin is an important hormone that plays a crucial role in maintaining metabolic health, and its levels may serve as a useful biomarker for assessing metabolic risk.

Patient education, as defined by the US National Library of Medicine's Medical Subject Headings (MeSH), is "the teaching or training of patients concerning their own health needs. It includes the patient's understanding of his or her condition and the necessary procedures for self, assisted, or professional care." This encompasses a wide range of activities and interventions aimed at helping patients and their families understand their medical conditions, treatment options, self-care skills, and overall health management. Effective patient education can lead to improved health outcomes, increased patient satisfaction, and better use of healthcare resources.

Incretins are hormones that are released from the gut in response to food intake, with two major types being glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate the pancreas to produce insulin, suppress the release of glucagon from the pancreas, slow down gastric emptying, and promote satiety. Incretins play a significant role in regulating blood sugar levels after meals, and medications that mimic or enhance incretin action are used in the treatment of type 2 diabetes.

Oxidative stress is defined as an imbalance between the production of reactive oxygen species (free radicals) and the body's ability to detoxify them or repair the damage they cause. This imbalance can lead to cellular damage, oxidation of proteins, lipids, and DNA, disruption of cellular functions, and activation of inflammatory responses. Prolonged or excessive oxidative stress has been linked to various health conditions, including cancer, cardiovascular diseases, neurodegenerative disorders, and aging-related diseases.

Glomerular filtration rate (GFR) is a test used to check how well the kidneys are working. Specifically, it estimates how much blood passes through the glomeruli each minute. The glomeruli are the tiny fibers in the kidneys that filter waste from the blood. A lower GFR number means that the kidneys aren't working properly and may indicate kidney disease.

The GFR is typically calculated using a formula that takes into account the patient's serum creatinine level, age, sex, and race. The most commonly used formula is the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation. A normal GFR is usually above 90 mL/min/1.73m2, but this can vary depending on the individual's age and other factors.

Venom is a complex mixture of toxic compounds produced by certain animals, such as snakes, spiders, scorpions, and marine creatures like cone snails and stonefish. These toxic substances are specifically designed to cause damage to the tissues or interfere with the normal physiological processes of other organisms, which can lead to harmful or even lethal effects.

Venoms typically contain a variety of components, including enzymes, peptides, proteins, and small molecules, each with specific functions that contribute to the overall toxicity of the mixture. Some of these components may cause localized damage, such as tissue necrosis or inflammation, while others can have systemic effects, impacting various organs and bodily functions.

The study of venoms, known as toxinology, has important implications for understanding the evolution of animal behavior, developing new therapeutics, and advancing medical treatments for envenomation (the process of being poisoned by venom). Additionally, venoms have been used in traditional medicine for centuries, and ongoing research continues to uncover novel compounds with potential applications in modern pharmacology.

Prognosis is a medical term that refers to the prediction of the likely outcome or course of a disease, including the chances of recovery or recurrence, based on the patient's symptoms, medical history, physical examination, and diagnostic tests. It is an important aspect of clinical decision-making and patient communication, as it helps doctors and patients make informed decisions about treatment options, set realistic expectations, and plan for future care.

Prognosis can be expressed in various ways, such as percentages, categories (e.g., good, fair, poor), or survival rates, depending on the nature of the disease and the available evidence. However, it is important to note that prognosis is not an exact science and may vary depending on individual factors, such as age, overall health status, and response to treatment. Therefore, it should be used as a guide rather than a definitive forecast.

Hyperinsulinism is a medical condition characterized by an excess production and release of insulin from the pancreas. Insulin is a hormone that helps regulate blood sugar levels by allowing cells in the body to take in sugar (glucose) for energy or storage. In hyperinsulinism, the increased insulin levels can cause low blood sugar (hypoglycemia), which can lead to symptoms such as sweating, shaking, confusion, and in severe cases, seizures or loss of consciousness.

There are several types of hyperinsulinism, including congenital forms that are present at birth and acquired forms that develop later in life. Congenital hyperinsulinism is often caused by genetic mutations that affect the way insulin is produced or released from the pancreas. Acquired hyperinsulinism can be caused by factors such as certain medications, hormonal disorders, or tumors of the pancreas.

Treatment for hyperinsulinism depends on the underlying cause and severity of the condition. Treatment options may include dietary changes, medication to reduce insulin secretion, or surgery to remove part or all of the pancreas.

HDL (High-Density Lipoprotein) cholesterol is often referred to as "good" cholesterol. It is a type of lipoprotein that helps remove excess cholesterol from cells and carry it back to the liver, where it can be broken down and removed from the body. High levels of HDL cholesterol have been associated with a lower risk of heart disease and stroke.

"Age distribution" is a term used to describe the number of individuals within a population or sample that fall into different age categories. It is often presented in the form of a graph, table, or chart, and can provide important information about the demographic structure of a population.

The age distribution of a population can be influenced by a variety of factors, including birth rates, mortality rates, migration patterns, and aging. Public health officials and researchers use age distribution data to inform policies and programs related to healthcare, social services, and other areas that affect the well-being of populations.

For example, an age distribution graph might show a larger number of individuals in the younger age categories, indicating a population with a high birth rate. Alternatively, it might show a larger number of individuals in the older age categories, indicating a population with a high life expectancy or an aging population. Understanding the age distribution of a population can help policymakers plan for future needs and allocate resources more effectively.

Myocardial infarction (MI), also known as a heart attack, is a medical condition characterized by the death of a segment of heart muscle (myocardium) due to the interruption of its blood supply. This interruption is most commonly caused by the blockage of a coronary artery by a blood clot formed on the top of an atherosclerotic plaque, which is a buildup of cholesterol and other substances in the inner lining of the artery.

The lack of oxygen and nutrients supply to the heart muscle tissue results in damage or death of the cardiac cells, causing the affected area to become necrotic. The extent and severity of the MI depend on the size of the affected area, the duration of the occlusion, and the presence of collateral circulation.

Symptoms of a myocardial infarction may include chest pain or discomfort, shortness of breath, nausea, lightheadedness, and sweating. Immediate medical attention is necessary to restore blood flow to the affected area and prevent further damage to the heart muscle. Treatment options for MI include medications, such as thrombolytics, antiplatelet agents, and pain relievers, as well as procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).

Cholesterol is a type of lipid (fat) molecule that is an essential component of cell membranes and is also used to make certain hormones and vitamins in the body. It is produced by the liver and is also obtained from animal-derived foods such as meat, dairy products, and eggs.

Cholesterol does not mix with blood, so it is transported through the bloodstream by lipoproteins, which are particles made up of both lipids and proteins. There are two main types of lipoproteins that carry cholesterol: low-density lipoproteins (LDL), also known as "bad" cholesterol, and high-density lipoproteins (HDL), also known as "good" cholesterol.

High levels of LDL cholesterol in the blood can lead to a buildup of cholesterol in the walls of the arteries, increasing the risk of heart disease and stroke. On the other hand, high levels of HDL cholesterol are associated with a lower risk of these conditions because HDL helps remove LDL cholesterol from the bloodstream and transport it back to the liver for disposal.

It is important to maintain healthy levels of cholesterol through a balanced diet, regular exercise, and sometimes medication if necessary. Regular screening is also recommended to monitor cholesterol levels and prevent health complications.

Antihypertensive agents are a class of medications used to treat high blood pressure (hypertension). They work by reducing the force and rate of heart contractions, dilating blood vessels, or altering neurohormonal activation to lower blood pressure. Examples include diuretics, beta blockers, ACE inhibitors, ARBs, calcium channel blockers, and direct vasodilators. These medications may be used alone or in combination to achieve optimal blood pressure control.

Creatinine is a waste product that's produced by your muscles and removed from your body by your kidneys. Creatinine is a breakdown product of creatine, a compound found in meat and fish, as well as in the muscles of vertebrates, including humans.

In healthy individuals, the kidneys filter out most of the creatinine and eliminate it through urine. However, when the kidneys are not functioning properly, creatinine levels in the blood can rise. Therefore, measuring the amount of creatinine in the blood or urine is a common way to test how well the kidneys are working. High creatinine levels in the blood may indicate kidney damage or kidney disease.

Atherosclerosis is a medical condition characterized by the buildup of plaques, made up of fat, cholesterol, calcium, and other substances found in the blood, on the inner walls of the arteries. This process gradually narrows and hardens the arteries, reducing the flow of oxygen-rich blood to various parts of the body. Atherosclerosis can affect any artery in the body, including those that supply blood to the heart (coronary arteries), brain, limbs, and other organs. The progressive narrowing and hardening of the arteries can lead to serious complications such as coronary artery disease, carotid artery disease, peripheral artery disease, and aneurysms, which can result in heart attacks, strokes, or even death if left untreated.

The exact cause of atherosclerosis is not fully understood, but it is believed to be associated with several risk factors, including high blood pressure, high cholesterol levels, smoking, diabetes, obesity, physical inactivity, and a family history of the condition. Atherosclerosis can often progress without any symptoms for many years, but as the disease advances, it can lead to various signs and symptoms depending on which arteries are affected. Treatment typically involves lifestyle changes, medications, and, in some cases, surgical procedures to restore blood flow.

Diabetes Mellitus, Lipoatrophic is not a recognized medical term or official classification for diabetes. However, Lipodystrophy is a condition that can occur in some people with diabetes, particularly those being treated with insulin. Lipodystrophy refers to the loss of fat tissue, which can cause changes in the way the body responds to insulin and lead to difficulties controlling blood sugar levels. There are different types of lipodystrophy, including localized lipoatrophy (small areas of fat loss) and generalized lipodystrophy (widespread fat loss).

In people with Diabetes Mellitus, Lipodystrophy can lead to an increased need for insulin, as well as other metabolic complications. It is important for individuals with diabetes who notice changes in their body's response to insulin or unusual fat distribution to consult with their healthcare provider for further evaluation and management.

Single Nucleotide Polymorphism (SNP) is a type of genetic variation that occurs when a single nucleotide (A, T, C, or G) in the DNA sequence is altered. This alteration must occur in at least 1% of the population to be considered a SNP. These variations can help explain why some people are more susceptible to certain diseases than others and can also influence how an individual responds to certain medications. SNPs can serve as biological markers, helping scientists locate genes that are associated with disease. They can also provide information about an individual's ancestry and ethnic background.

A chronic disease is a long-term medical condition that often progresses slowly over a period of years and requires ongoing management and care. These diseases are typically not fully curable, but symptoms can be managed to improve quality of life. Common chronic diseases include heart disease, stroke, cancer, diabetes, arthritis, and COPD (chronic obstructive pulmonary disease). They are often associated with advanced age, although they can also affect children and younger adults. Chronic diseases can have significant impacts on individuals' physical, emotional, and social well-being, as well as on healthcare systems and society at large.

The "age of onset" is a medical term that refers to the age at which an individual first develops or displays symptoms of a particular disease, disorder, or condition. It can be used to describe various medical conditions, including both physical and mental health disorders. The age of onset can have implications for prognosis, treatment approaches, and potential causes of the condition. In some cases, early onset may indicate a more severe or progressive course of the disease, while late-onset symptoms might be associated with different underlying factors or etiologies. It is essential to provide accurate and precise information regarding the age of onset when discussing a patient's medical history and treatment plan.

LDL, or low-density lipoprotein, is often referred to as "bad" cholesterol. It is one of the lipoproteins that helps carry cholesterol throughout your body. High levels of LDL cholesterol can lead to a buildup of cholesterol in your arteries, which can increase the risk of heart disease and stroke.

Cholesterol is a type of fat (lipid) that is found in the cells of your body. Your body needs some cholesterol to function properly, but having too much can lead to health problems. LDL cholesterol is one of the two main types of cholesterol; the other is high-density lipoprotein (HDL), or "good" cholesterol.

It's important to keep your LDL cholesterol levels in a healthy range to reduce your risk of developing heart disease and stroke. A healthcare professional can help you determine what your target LDL cholesterol level should be based on your individual health status and risk factors.

A diet, in medical terms, refers to the planned and regular consumption of food and drinks. It is a balanced selection of nutrient-rich foods that an individual eats on a daily or periodic basis to meet their energy needs and maintain good health. A well-balanced diet typically includes a variety of fruits, vegetables, whole grains, lean proteins, and low-fat dairy products.

A diet may also be prescribed for therapeutic purposes, such as in the management of certain medical conditions like diabetes, hypertension, or obesity. In these cases, a healthcare professional may recommend specific restrictions or modifications to an individual's regular diet to help manage their condition and improve their overall health.

It is important to note that a healthy and balanced diet should be tailored to an individual's age, gender, body size, activity level, and any underlying medical conditions. Consulting with a healthcare professional, such as a registered dietitian or nutritionist, can help ensure that an individual's dietary needs are being met in a safe and effective way.

HLA-DQ antigens are a type of human leukocyte antigen (HLA) that are found on the surface of cells in our body. They are a part of the major histocompatibility complex (MHC) class II molecules, which play a crucial role in the immune system by presenting pieces of proteins from outside the cell to CD4+ T cells, also known as helper T cells. This presentation process is essential for initiating an appropriate immune response against potentially harmful pathogens such as bacteria and viruses.

HLA-DQ antigens are encoded by genes located on chromosome 6p21.3 in the HLA region. Each individual inherits a pair of HLA-DQ genes, one from each parent, which can result in various combinations of HLA-DQ alleles. These genetic variations contribute to the diversity of immune responses among different individuals.

HLA-DQ antigens consist of two noncovalently associated polypeptide chains: an alpha (DQA) chain and a beta (DQB) chain. There are several isotypes of HLA-DQ antigens, including DQ1, DQ2, DQ3, DQ4, DQ5, DQ6, DQ7, DQ8, and DQ9, which are determined by the specific combination of DQA and DQB alleles.

Certain HLA-DQ genotypes have been associated with an increased risk of developing certain autoimmune diseases, such as celiac disease (DQ2 and DQ8), type 1 diabetes (DQ2, DQ8), and rheumatoid arthritis (DQ4). Understanding the role of HLA-DQ antigens in these conditions can provide valuable insights into disease pathogenesis and potential therapeutic targets.

Genetic polymorphism refers to the occurrence of multiple forms (called alleles) of a particular gene within a population. These variations in the DNA sequence do not generally affect the function or survival of the organism, but they can contribute to differences in traits among individuals. Genetic polymorphisms can be caused by single nucleotide changes (SNPs), insertions or deletions of DNA segments, or other types of genetic rearrangements. They are important for understanding genetic diversity and evolution, as well as for identifying genetic factors that may contribute to disease susceptibility in humans.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

Advanced Glycosylation End Products (AGEs) are formed through the non-enzymatic glycation and oxidative modification of proteins, lipids, and nucleic acids. This process occurs when a sugar molecule, such as glucose, binds to a protein or lipid without the regulation of an enzyme, leading to the formation of a Schiff base. This then rearranges to form a more stable ketoamine, known as an Amadori product. Over time, these Amadori products can undergo further reactions, including oxidation, fragmentation, and cross-linking, resulting in the formation of AGEs.

AGEs can alter the structure and function of proteins and lipids, leading to damage in tissues and organs. They have been implicated in the development and progression of several age-related diseases, including diabetes, atherosclerosis, kidney disease, and Alzheimer's disease. AGEs can also contribute to inflammation and oxidative stress, which can further exacerbate tissue damage.

In summary, Advanced Glycosylation End Products (AGEs) are the result of non-enzymatic glycation and oxidation of proteins, lipids, and nucleic acids, leading to structural and functional changes in tissues and organs, and contributing to the development and progression of several age-related diseases.

Longitudinal studies are a type of research design where data is collected from the same subjects repeatedly over a period of time, often years or even decades. These studies are used to establish patterns of changes and events over time, and can help researchers identify causal relationships between variables. They are particularly useful in fields such as epidemiology, psychology, and sociology, where the focus is on understanding developmental trends and the long-term effects of various factors on health and behavior.

In medical research, longitudinal studies can be used to track the progression of diseases over time, identify risk factors for certain conditions, and evaluate the effectiveness of treatments or interventions. For example, a longitudinal study might follow a group of individuals over several decades to assess their exposure to certain environmental factors and their subsequent development of chronic diseases such as cancer or heart disease. By comparing data collected at multiple time points, researchers can identify trends and correlations that may not be apparent in shorter-term studies.

Longitudinal studies have several advantages over other research designs, including their ability to establish temporal relationships between variables, track changes over time, and reduce the impact of confounding factors. However, they also have some limitations, such as the potential for attrition (loss of participants over time), which can introduce bias and affect the validity of the results. Additionally, longitudinal studies can be expensive and time-consuming to conduct, requiring significant resources and a long-term commitment from both researchers and study participants.

Diabetic cardiomyopathy is a specific type of heart disease that occurs in people with diabetes. It is characterized by structural and functional changes in the heart muscle (myocardium), which can lead to impaired heart function and, ultimately, heart failure.

The exact mechanisms underlying diabetic cardiomyopathy are not fully understood, but it is believed to be related to a combination of metabolic abnormalities, inflammation, oxidative stress, and microvascular dysfunction that occur in diabetes. These factors can lead to changes in the heart muscle cells, including increased stiffness, altered contractility, and cell death, as well as interstitial fibrosis and remodeling of the extracellular matrix.

Diabetic cardiomyopathy is often asymptomatic in its early stages but can lead to symptoms such as shortness of breath, fatigue, fluid retention, and irregular heart rhythms as it progresses. Diagnosis typically involves a combination of medical history, physical examination, electrocardiogram (ECG), echocardiography, and other imaging tests, as well as laboratory tests to assess cardiac function and metabolic status.

Treatment of diabetic cardiomyopathy typically involves managing underlying diabetes and associated risk factors such as hypertension, dyslipidemia, and obesity. Medications such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), beta-blockers, and diuretics may also be used to improve heart function and reduce symptoms. Lifestyle modifications such as regular exercise, smoking cessation, and a healthy diet are also important components of management.

Endocrinology is a branch of medicine that deals with the endocrine system, which consists of glands and organs that produce, store, and secrete hormones. Hormones are chemical messengers that regulate various functions in the body, such as metabolism, growth and development, tissue function, sexual function, reproduction, sleep, and mood.

Endocrinologists are medical doctors who specialize in diagnosing and treating conditions related to the endocrine system, including diabetes, thyroid disorders, pituitary gland tumors, adrenal gland disorders, osteoporosis, and sexual dysfunction. They use various diagnostic tests, such as blood tests, imaging studies, and biopsies, to evaluate hormone levels and function. Treatment options may include medication, lifestyle changes, and surgery.

In summary, endocrinology is the medical specialty focused on the study, diagnosis, and treatment of disorders related to the endocrine system and its hormones.

Combination drug therapy is a treatment approach that involves the use of multiple medications with different mechanisms of action to achieve better therapeutic outcomes. This approach is often used in the management of complex medical conditions such as cancer, HIV/AIDS, and cardiovascular diseases. The goal of combination drug therapy is to improve efficacy, reduce the risk of drug resistance, decrease the likelihood of adverse effects, and enhance the overall quality of life for patients.

In combining drugs, healthcare providers aim to target various pathways involved in the disease process, which may help to:

1. Increase the effectiveness of treatment by attacking the disease from multiple angles.
2. Decrease the dosage of individual medications, reducing the risk and severity of side effects.
3. Slow down or prevent the development of drug resistance, a common problem in chronic diseases like HIV/AIDS and cancer.
4. Improve patient compliance by simplifying dosing schedules and reducing pill burden.

Examples of combination drug therapy include:

1. Antiretroviral therapy (ART) for HIV treatment, which typically involves three or more drugs from different classes to suppress viral replication and prevent the development of drug resistance.
2. Chemotherapy regimens for cancer treatment, where multiple cytotoxic agents are used to target various stages of the cell cycle and reduce the likelihood of tumor cells developing resistance.
3. Cardiovascular disease management, which may involve combining medications such as angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, diuretics, and statins to control blood pressure, heart rate, fluid balance, and cholesterol levels.
4. Treatment of tuberculosis, which often involves a combination of several antibiotics to target different aspects of the bacterial life cycle and prevent the development of drug-resistant strains.

When prescribing combination drug therapy, healthcare providers must carefully consider factors such as potential drug interactions, dosing schedules, adverse effects, and contraindications to ensure safe and effective treatment. Regular monitoring of patients is essential to assess treatment response, manage side effects, and adjust the treatment plan as needed.

Adamantane is a chemical compound with the formula C10H16. It is a hydrocarbon that consists of a cage-like structure of carbon atoms, making it one of the simplest diamondoid compounds. The term "adamantane" is also used more broadly to refer to any compound that contains this characteristic carbon cage structure.

In the context of medicine, adamantane derivatives are a class of antiviral drugs that have been used to treat and prevent influenza A infections. These drugs work by binding to the M2 protein of the influenza virus, which is essential for viral replication. By blocking the function of this protein, adamantane derivatives can prevent the virus from multiplying within host cells.

Examples of adamantane derivatives used in medicine include amantadine and rimantadine. These drugs are typically administered orally and have been shown to be effective at reducing the severity and duration of influenza A symptoms, particularly when used early in the course of infection. However, resistance to these drugs has become increasingly common among circulating strains of influenza A virus, which has limited their usefulness in recent years.

Pancreas transplantation is a surgical procedure that involves implanting a healthy pancreas from a deceased donor into a recipient with diabetes. The primary goal of this procedure is to restore the recipient's insulin production and eliminate the need for insulin injections, thereby improving their quality of life and reducing the risk of long-term complications associated with diabetes.

There are three main types of pancreas transplantation:

1. Simultaneous pancreas-kidney (SPK) transplantation: This is the most common type of pancreas transplant, performed simultaneously with a kidney transplant in patients with diabetes and end-stage renal disease (ESRD). The new pancreas not only restores insulin production but also helps prevent further kidney damage.
2. Pancreas after kidney (PAK) transplantation: In this procedure, a patient receives a kidney transplant first, followed by a pancreas transplant at a later time. This is typically performed in patients who have already undergone a successful kidney transplant and wish to improve their diabetes management.
3. Pancreas transplantation alone (PTA): In rare cases, a pancreas transplant may be performed without a concurrent kidney transplant. This is usually considered for patients with brittle diabetes who experience severe hypoglycemic episodes despite optimal medical management and lifestyle modifications.

The success of pancreas transplantation has significantly improved over the years, thanks to advancements in surgical techniques, immunosuppressive medications, and post-transplant care. However, it is essential to weigh the benefits against the risks, such as potential complications related to surgery, infection, rejection, and long-term use of immunosuppressive drugs. Ultimately, the decision to undergo pancreas transplantation should be made in consultation with a multidisciplinary team of healthcare professionals, considering each patient's unique medical history and personal circumstances.

I'm sorry for any confusion, but "Rats, Zucker" is not a standard medical term or abbreviation in human medicine. It seems to be an incorrect combination of two terms from the field of laboratory animal science.

1. "Rats" are commonly used laboratory animals.
2. "Zucker" is a surname and also refers to a strain of laboratory rats, specifically the Zucker Diabetic Fatty (ZDF) rat, which is a model for studying type 2 diabetes mellitus.

If you have any questions related to human medicine or healthcare, I would be happy to help clarify those for you.

Weight loss is a reduction in body weight attributed to loss of fluid, fat, muscle, or bone mass. It can be intentional through dieting and exercise or unintentional due to illness or disease. Unintentional weight loss is often a cause for concern and should be evaluated by a healthcare professional to determine the underlying cause and develop an appropriate treatment plan. Rapid or significant weight loss can also have serious health consequences, so it's important to approach any weight loss plan in a healthy and sustainable way.

I believe you are looking for a medical condition or term related to the state of Arizona. However, there is no specific medical condition or term named "Arizona." If you're looking for medical conditions or healthcare-related information specific to Arizona, I could provide some general statistics or facts about healthcare in Arizona. Please clarify if this is not what you were looking for.

Arizona has a diverse population and unique healthcare needs. Here are some key points related to healthcare in Arizona:

1. Chronic diseases: Arizona experiences high rates of chronic diseases, such as diabetes and cardiovascular disease, which can lead to various health complications if not managed properly.
2. Mental health: Access to mental health services is a concern in Arizona, with a significant portion of the population living in areas with mental health professional shortages.
3. Rural healthcare: Rural communities in Arizona often face challenges accessing quality healthcare due to provider shortages and longer travel distances to medical facilities.
4. COVID-19 pandemic: Like other states, Arizona has been affected by the COVID-19 pandemic, which has strained healthcare resources and highlighted existing health disparities among various populations.
5. Indigenous communities: Arizona is home to several indigenous communities, including the Navajo Nation, which faces significant health challenges, such as higher rates of diabetes, heart disease, and COVID-19 infections compared to the general population.

If you were looking for information on a specific medical condition or term related to Arizona, please provide more context so I can give a more accurate response.

A confidence interval (CI) is a range of values that is likely to contain the true value of a population parameter with a certain level of confidence. It is commonly used in statistical analysis to express the uncertainty associated with estimates derived from sample data.

For example, if we calculate a 95% confidence interval for the mean height of a population based on a sample of individuals, we can say that we are 95% confident that the true population mean height falls within the calculated range. The width of the confidence interval gives us an idea of how precise our estimate is - narrower intervals indicate more precise estimates, while wider intervals suggest greater uncertainty.

Confidence intervals are typically calculated using statistical formulas that take into account the sample size, standard deviation, and level of confidence desired. They can be used to compare different groups or to evaluate the effectiveness of interventions in medical research.

Exercise is defined in the medical context as a physical activity that is planned, structured, and repetitive, with the primary aim of improving or maintaining one or more components of physical fitness. Components of physical fitness include cardiorespiratory endurance, muscular strength, muscular endurance, flexibility, and body composition. Exercise can be classified based on its intensity (light, moderate, or vigorous), duration (length of time), and frequency (number of times per week). Common types of exercise include aerobic exercises, such as walking, jogging, cycling, and swimming; resistance exercises, such as weightlifting; flexibility exercises, such as stretching; and balance exercises. Exercise has numerous health benefits, including reducing the risk of chronic diseases, improving mental health, and enhancing overall quality of life.

I'm sorry for any confusion, but "Linear Models" is actually a term from the field of statistics and machine learning, rather than medicine. A linear model is a type of statistical model that is used to analyze the relationship between two or more variables. In a linear model, the relationship between the dependent variable (the outcome or result) and the independent variable(s) (the factors being studied) is assumed to be linear, meaning that it can be described by a straight line on a graph.

The equation for a simple linear model with one independent variable (x) and one dependent variable (y) looks like this:

y = β0 + β1*x + ε

In this equation, β0 is the y-intercept or the value of y when x equals zero, β1 is the slope or the change in y for each unit increase in x, and ε is the error term or the difference between the actual values of y and the predicted values of y based on the linear model.

Linear models are widely used in medical research to study the relationship between various factors (such as exposure to a risk factor or treatment) and health outcomes (such as disease incidence or mortality). They can also be used to adjust for confounding variables, which are factors that may influence both the independent variable and the dependent variable, and thus affect the observed relationship between them.

Smoking is not a medical condition, but it's a significant health risk behavior. Here is the definition from a public health perspective:

Smoking is the act of inhaling and exhaling the smoke of burning tobacco that is commonly consumed through cigarettes, pipes, and cigars. The smoke contains over 7,000 chemicals, including nicotine, tar, carbon monoxide, and numerous toxic and carcinogenic substances. These toxins contribute to a wide range of diseases and health conditions, such as lung cancer, heart disease, stroke, chronic obstructive pulmonary disease (COPD), and various other cancers, as well as adverse reproductive outcomes and negative impacts on the developing fetus during pregnancy. Smoking is highly addictive due to the nicotine content, which makes quitting smoking a significant challenge for many individuals.

The Glycemic Index (GI) is a measure of how quickly a carbohydrate-containing food raises blood glucose levels, compared to a reference food (usually pure glucose). It is expressed as a percentage on a scale from 0 to 100. A food with a high GI raises blood glucose levels more rapidly and higher than a food with a low GI.

Foods are ranked based on the speed at which they cause an increase in blood sugar levels, with high GI foods causing a rapid spike and low GI foods causing a slower, more gradual rise. This can be useful for people managing diabetes or other conditions where maintaining stable blood glucose levels is important.

It's worth noting that the glycemic index of a food can vary depending on factors such as ripeness, cooking method, and the presence of fiber or fat in the meal. Therefore, it's best to consider GI values as a general guide rather than an absolute rule.

"Wistar rats" are a strain of albino rats that are widely used in laboratory research. They were developed at the Wistar Institute in Philadelphia, USA, and were first introduced in 1906. Wistar rats are outbred, which means that they are genetically diverse and do not have a fixed set of genetic characteristics like inbred strains.

Wistar rats are commonly used as animal models in biomedical research because of their size, ease of handling, and relatively low cost. They are used in a wide range of research areas, including toxicology, pharmacology, nutrition, cancer, cardiovascular disease, and behavioral studies. Wistar rats are also used in safety testing of drugs, medical devices, and other products.

Wistar rats are typically larger than many other rat strains, with males weighing between 500-700 grams and females weighing between 250-350 grams. They have a lifespan of approximately 2-3 years. Wistar rats are also known for their docile and friendly nature, making them easy to handle and work with in the laboratory setting.

A kidney, in medical terms, is one of two bean-shaped organs located in the lower back region of the body. They are essential for maintaining homeostasis within the body by performing several crucial functions such as:

1. Regulation of water and electrolyte balance: Kidneys help regulate the amount of water and various electrolytes like sodium, potassium, and calcium in the bloodstream to maintain a stable internal environment.

2. Excretion of waste products: They filter waste products from the blood, including urea (a byproduct of protein metabolism), creatinine (a breakdown product of muscle tissue), and other harmful substances that result from normal cellular functions or external sources like medications and toxins.

3. Endocrine function: Kidneys produce several hormones with important roles in the body, such as erythropoietin (stimulates red blood cell production), renin (regulates blood pressure), and calcitriol (activated form of vitamin D that helps regulate calcium homeostasis).

4. pH balance regulation: Kidneys maintain the proper acid-base balance in the body by excreting either hydrogen ions or bicarbonate ions, depending on whether the blood is too acidic or too alkaline.

5. Blood pressure control: The kidneys play a significant role in regulating blood pressure through the renin-angiotensin-aldosterone system (RAAS), which constricts blood vessels and promotes sodium and water retention to increase blood volume and, consequently, blood pressure.

Anatomically, each kidney is approximately 10-12 cm long, 5-7 cm wide, and 3 cm thick, with a weight of about 120-170 grams. They are surrounded by a protective layer of fat and connected to the urinary system through the renal pelvis, ureters, bladder, and urethra.

"Rats, Inbred OLETF" is a specific strain of laboratory rats used in medical research. "OLETF" stands for "Otsuka Long-Evans Tokushima Fatty," which refers to the fact that this strain was developed by crossbreeding and inbreeding Long-Evans rats from the University of Kyoto with local wild rats in Tokushima, Japan, by Otsuka Pharmaceutical Co.

The OLETF rat is a model for studying obesity, type 2 diabetes, and related metabolic disorders. These rats have a genetic mutation that impairs the function of their cholecystokinin-1 (CCK-1) receptors, which are involved in regulating satiety and insulin secretion. As a result, OLETF rats become obese and develop type 2 diabetes as they age.

Inbred strains like the OLETF rat are useful for medical research because they have a consistent genetic background, making it easier to control variables and study the effects of specific genes or interventions. However, it's important to note that results from animal studies may not always translate directly to humans, so further research is needed to confirm any findings.

Diabetes Mellitus. Elsevier España. pp. 327-. ISBN 978-84-8086-683-5. Retrieved 18 May 2010. v t e (Articles with short ... Serrano Ríos; M. Type 2. ...
Insulin-dependent diabetes mellitus (IDDM) An out-of-date term for Type 1 diabetes mellitus. See: Type 1 diabetes mellitus. ... Diabetes insipidus a type of diabetes (excess urination) unrelated to diabetes mellitus. Diabetes mellitus A disease that ... "juvenile diabetes," "juvenile-onset diabetes" and "ketosis-prone diabetes." Diabetes mellitus type 2 The most common form of ... Juvenile onset diabetes Former term for insulin-dependent or type I diabetes. See: Insulin-dependent diabetes mellitus. ...
Kelvin Okoth (2022). "Long term miscarriage-related hypertension and diabetes mellitus. Evidence from a United Kingdom ... Miscarriages can create a greater risk of high blood pressure, cardiovascular diseases, and type 2 diabetes. About 3% also ... This is partly due to lack of insurance before pregnancy and higher rates of chronic conditions, such as obesity and diabetes. ... is the most common type. In 2015, 1.7% of all live births in the U.S. were the result of ART. While this method of conception ...
It is often found on the shin.There is also neuropathy; also associated with diabetes mellitus; type 1 and 2.[citation needed] ... Cole, Joanne B.; Florez, Jose C. (2020). "Genetics of diabetes mellitus and diabetes complications". Nature Reviews Nephrology ... Diabetes mellitus is the most common cause of adult kidney failure worldwide. It also the most common cause of amputation in ... Shi, Yi; Vanhoutte, Paul M. (2017). "Macro- and microvascular endothelial dysfunction in diabetes". Journal of Diabetes (in ...
... from the Cochrane Collaboration published a meta-analysis of their own on the use of rosiglitazone in Type II diabetes, ... "Call to 'suspend' diabetes drug". BBC News. 2010-09-23. "Drugs banned in India". Central Drugs Standard Control Organization, ... "Diabetes drug withdrawn". Stuff.co.nz. NZPA. 17 February 2011. Archived from the original on 13 October 2013. Retrieved 5 ... "Diabetes drug to be withdrawn over heart risk fears". New Zealand Herald. Feb 17, 2011. "Withdrawal of rosiglitazone-containing ...
"Diabetes Mellitus, Type 2 - MeSH - NCBI". www.ncbi.nlm.nih.gov. "Bibliography". wayback.archive-it.org. "Qualifiers - 2009". ... The remaining two types of term are those that describe the type of material that the article represents (publication types), ... See the MeSH description for diabetes type 2 as an example. The explanatory text is written by the MeSH team based on their ... The second type of term, MeSH subheadings or qualifiers (see below), can be used with MeSH terms to more completely describe a ...
"The relationship of cardiac diastolic dysfunction to concurrent hormonal and metabolic status in type I diabetes mellitus". J ... A rationale for therapeutic decision making in individuals with coexistent diabetes mellitus and HF is less clear because there ... "Diabetes Blue Circle Symbol". International Diabetes Federation. 17 March 2006. Archived from the original on 5 August 2007. ... Severson DL (October 2004). "Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes". Can J ...
For example, humans produce amylin, an amyloidogenic peptide associated with type II diabetes, but in rats and mice prolines ... Haataja L, Gurlo T, Huang CJ, Butler PC (May 2008). "Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis". ... Höppener JW, Ahrén B, Lips CJ (August 2000). "Islet amyloid and type 2 diabetes mellitus". The New England Journal of Medicine ... Although bona fide amyloid structures always are based on intermolecular β-sheets, different types of "higher order" tertiary ...
High adiponectin levels correlate with a lower risk of diabetes mellitus type 2. Plasma levels of adiponectin are lower in ... A low level of adiponectin is an independent risk factor for developing: Metabolic syndrome Diabetes mellitus Dyslipidemia ... Diabetes. 55 (1): 141-147. doi:10.2337/diabetes.55.1.141. PMID 16380487. Hoffstedt J, Arvidsson E, Sjölin E, Wåhlén K, Arner P ... Li S, Shin HJ, Ding EL, van Dam RM (July 2009). "Adiponectin levels and risk of type 2 diabetes: a systematic review and meta- ...
There is little evidence that Momordica charantia has uses against cancer, diabetes, fever, HIV and AIDS, or infections. While ... Ooi, Cheow Peng; Yassin, Zaitun; Hamid, Tengku-Aizan (15 August 2012). "Momordica charantia for type 2 diabetes mellitus" (PDF ... 96 (1-2): 49-55. doi:10.1016/j.jep.2004.08.009. PMID 15588650. Joseph, B.; Jini, D. (2013). "Antidiabetic effects of Momordica ... 3 (2): 93-102. doi:10.1016/S2222-1808(13)60052-3. PMC 4027280. "Bitter Melon". Memorial Sloan-Kettering Cancer Center. ...
One 2015 review found little evidence for use of resveratrol to treat diabetes. A 2015 meta-analysis found little evidence for ... Resveratrol (3,5,4′-trihydroxy-trans-stilbene) is a stilbenoid, a type of natural phenol, and a phytoalexin produced by several ... One review found limited evidence that resveratrol lowered fasting plasma glucose in people with diabetes. Two reviews ... Hausenblas HA, Schoulda JA, Smoliga JM (2015). "Resveratrol treatment as an adjunct to pharmacological management in type 2 ...
Sheu, WH-H; Lee, I-T; Chen, W; Chan, Y-C (2008). "Effects of xylooligosaccharides in type 2 diabetes mellitus". J Nutr Sci ...
"Screening for Type II Diabetes Mellitus in the United States: The Present and the Future". Clinical Medicine Insights. ... American Diabetes Association (January 2005). "Diagnosis and classification of diabetes mellitus". Diabetes Care. 28 (Suppl 1 ... Kraft JR (1975). "Detection of Diabetes Mellitus In Situ (Occult Diabetes)". Laboratory Medicine. 6 (2): 10-22. doi:10.1093/ ... "Diabetes Prevention Program (DPP)". 31 August 2021. American Diabetes Association. "How to Prevent or Delay Diabetes". Archived ...
... "latent autoimmune diabetes in adults" (LADA) (30), "type 1.5 diabetes" (31,32,33), and "slowly progressing type 1 diabetes" (34 ... Balasubramanyam A, Nalini R, Hampe CS, Maldonado M (May 2008). "Syndromes of ketosis-prone diabetes mellitus". Endocrine ... Ketosis-prone diabetes (KPD) is an intermediate form of diabetes that has some characteristics of type 1 and some of type 2 ... However, it is distinct from latent autoimmune diabetes of adults (LADA), a form of type 1 sometimes referred to as type 1.5 ...
... , sold under the brand name Byetta and Bydureon among others, is a medication used to treat diabetes mellitus type 2. ... Diabetes Drug Tied to New Deaths. The New York Times. August 26, 2008; accessed August 28, 2008. Lai SW, Muo CH, Liao KF, Sung ... Exenatide is used to treat type 2 diabetes mellitus as an add-on to metformin, a biguanide, or a combination of metformin and a ... Exenatide was approved by the FDA on April 28, 2005, for people whose diabetes is not well controlled on other oral medications ...
There is emerging evidence that cannabidiol may help slow cell damage in diabetes mellitus type 1. There is a lack of ... 2010). "The role of cannabis and cannabinoids in diabetes". The British Journal of Diabetes & Vascular Disease. 10 (6): 267-273 ... "Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes". Diabetes - Perspectives in Drug Therapy ( ... Cannabis use is linked to an increased risk of a type of testicular cancer. The association of cannabis use with head and neck ...
Highest Development Phases: Preclinical : Neurological disorders; Type 2 diabetes mellitus (Antiparkinsonian agents, Peptides, ...
It is not used for type 1 diabetes because in type 1 diabetes the pancreas is not able to produce insulin. Its use is ... Glimepiride is indicated to treat type 2 diabetes mellitus; its mode of action is to increase insulin secretion by the pancreas ... Davis SN (2004). "The role of glimepiride in the effective management of Type 2 diabetes". J. Diabetes Complicat. 18 (6): 367- ... Glimepiride is an antidiabetic medication within the sulfonylurea class, primarily prescribed for the management of type 2 ...
Used to treat type 2 diabetes, exenatide was developed from saliva compounds of the Gila monster, a venomous lizard. Microbes ... Shyangdan DS, Royle P, Clar C, Sharma P, Waugh N, Snaith A (October 2011). "Glucagon-like peptide analogues for type 2 diabetes ... mellitus". The Cochrane Database of Systematic Reviews. 2011 (10): CD006423. doi:10.1002/14651858.cd006423.pub2. PMC 6486297. ... An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type". Molecules (Basel, Switzerland). 22 (3): 368. doi: ...
... s or glinides are a class of drugs used to treat type 2 diabetes. Repaglinide (trade name Prandin) gained US Food ... Blicklé JF (April 2006). "Meglitinide analogues: a review of clinical data focused on recent trials". Diabetes & Metabolism. 32 ... non-fatal stroke or end-stage renal disease when comparing metformin monotherapy to meglitinide for the treatment of type 2 ... "Metformin monotherapy for adults with type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews. 2020 (6): ...
It is used to treat diabetes mellitus type 2. It is a long-acting first-generation sulfonylurea. Like other sulfonylureas, ... Chlorpropamide is also used in partial central diabetes insipidus. Maximal plasma concentrations are reached 3 to 5 hours after ... Diabetes. 11: 40-3. PMID 13893349. (CS1 German-language sources (de), Articles with short description, Short description ...
Recommendations have been made to stop prescribing aliskiren-containing medicines to patients with diabetes (type 1 or type 2) ... December 2012). "Cardiorenal end points in a trial of aliskiren for type 2 diabetes" (PDF). The New England Journal of Medicine ... Aliskiren has been shown to increase the likelihood of adverse cardiovascular outcomes in patients with diabetes and kidney or ... Ingelfinger JR (June 2008). "Aliskiren and dual therapy in type 2 diabetes mellitus". The New England Journal of Medicine. 358 ...
The term usually refers to a family of drugs used in the treatment of diabetes mellitus type 2 that were introduced in the late ... The only approved use of the thiazolidinediones is in diabetes mellitus type 2. According to a 2014 Cochrane systematic review ... "Avandia diabetes drug suspended". nhs.uk. 24 September 2010. Santo M (June 2011). "Diabetes Drug Actos Sales Suspended in ... Emerging role of protein kinases in diabetes mellitus: From mechanism to therapy (Volume 124 ed.). Academic Press. p. 47-85. ...
... or flexible insulin therapy is a therapeutic regimen for diabetes mellitus treatment. This newer ... treatment for a select group of patients but simply as standard care for most patients with type 1 diabetes. The insulin pump ... As a result, diabetes specialists have expended increasing effort to help most people with diabetes achieve blood glucose ... Long-term studies like the UK Prospective Diabetes Study (UKPDS) and the Diabetes control and complications trial (DCCT) showed ...
"Associations of sex hormone-binding globulin and testosterone with diabetes among men and women (the Saku Diabetes study): a ... Inside the pocket of the domain is a serine residue that attracts the two different types of steroids at different points, thus ... Le TN, Nestler JE, Strauss JF, Wickham EP (January 2012). "Sex hormone-binding globulin and type 2 diabetes mellitus". Trends ... Low SHBG levels increase the probability of Type 2 Diabetes. SHBG levels increase with estrogenic states (oral contraceptives ...
Diabetes mellitus type 1 is a disease caused by the lack of insulin. Insulin must be used in type 1, which must be injected. ... Diabetes mellitus type 2 is a disease of insulin resistance by cells. Type 2 diabetes mellitus is the most common type of ... Drugs used in diabetes treat diabetes mellitus by altering the glucose level in the blood. With the exception of insulin, most ... They cannot be used with type 1 diabetes, or diabetes of pregnancy. They can be safely used with metformin or glitazones. The ...
It is less commonly used compared than statins because it treats a different type of cholesterol abnormality to statins. While ... longer duration of diabetes and had baseline neuropathy. Fenofibrate has an off-label use as an added therapy of high blood ... Steiner G (October 2009). "How can we improve the management of vascular risk in type 2 diabetes: insights from FIELD". ... It was initially indicated for diabetic retinopathy in patients with type 2 diabetes and diabetic retinopathy in Australia. The ...
Frank diabetes can be seen in 65-68% of women with this condition. Insulin resistance can be observed in both normal weight and ... Insulin resistance/type 2 diabetes. A review published in 2010 concluded that women with PCOS have an elevated prevalence of ... Metformin may not be effective in every type of PCOS, and therefore there is some disagreement about whether it should be used ... Metformin is a medication commonly used in type 2 diabetes mellitus to reduce insulin resistance, and is used off label (in the ...
This type of loss is usually only on one side (unilateral) and the severity of the loss varies. A common threshold of a "loss ... Common conditions that can increase the risk of hearing loss in elderly people are high blood pressure, diabetes, or the use of ... Management depends on the specific cause if known as well as the extent, type and configuration of the hearing loss. Sudden ... While everyone loses hearing with age, the amount and type of hearing loss is variable. Noise-induced hearing loss (NIHL), also ...
The insulin resistance that results from such a condition is a direct cause of diabetes onset. Diabetes mellitus is a disease ... Air pollutants can also cause other types of cancer. Another study found that the hazardous air pollutant (HAP) can cause ... "What is Diabetes? , NIDDK". National Institute of Diabetes and Digestive and Kidney Diseases. Archived from the original on ... As diabetes becomes a rising epidemic, the Center for Disease Control and Prevention estimates that up to nearly 8 million U.S ...
Specific associated variants increase the risk of type 2 diabetes 1. ... variants have been associated with type 2 diabetes in multiple ethnic groups. ... Worldwide distribution of type II diabetes-associated TCF7L2 SNPs: evidence for stratification in Europe. Biochem Genet. 2012 ... The Diabetes Gene and Wnt Pathway Effector TCF7L2 Regulates Adipocyte Development and Function. Diabetes. 2018 Apr. 67 (4):554- ...
Most pediatric patients with type 2 diabetes belong to minority communities. ... Although type 2 diabetes is widely diagnosed in adults, its frequency has markedly increased in the pediatric age group since ... Guideline] Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004 Jan. 27 Suppl 1:S5-S10. [QxMD MEDLINE Link]. ... independent of the type of diabetes. [37] Albuminuria is a risk factor for renal failure in pediatric type 2 diabetics. Youth ...
Type 2 Diabetes Mellitus and Increased Risk for Malaria Infection Ina Danquah, George Bedu-Addo, and Frank P. Mockenhaupt. ... Leaving all parameters in the model yielded an aOR for patients with type 2 diabetes mellitus of 1.36 (95% CI, 0.98-1.90; p = ... Type 2 Diabetes Mellitus and Increased Risk for Malaria Infection. ... Inserting any of the excluded variables back into the model did not change the aOR of patients with type 2 diabetes mellitus by ...
Most pediatric patients with type 2 diabetes belong to minority communities. ... Although type 2 diabetes is widely diagnosed in adults, its frequency has markedly increased in the pediatric age group since ... Guideline] Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004 Jan. 27 Suppl 1:S5-S10. [QxMD MEDLINE Link]. ... the European Association for the Study of Diabetes, and others, recommended HbA1c assay for the diagnosis of diabetes mellitus ...
Diabetes is a lifelong illness. However, people with type 2 diabetes can sometimes restore their blood sugar levels to normal ... People with diabetes may benefit from daily low-dose aspirin. When To Call a Professional. If you have diabetes, see your ... But it shares with type 1 diabetes high blood sugar levels, and the complications of high blood sugar. ... Obesity greatly increases the risk of diabetes.. Symptoms. The symptoms of diabetes are related to high blood glucose levels. ...
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009 Jan;32 Suppl 1:S62-7. ... International Diabetes Federation. IDF Diabetes Atlas. 15th ed. Brussels: International Diabetes Federation; 2011. ... Common polymorphisms in the adiponectin gene ACDC are not associated with diabetes in Pima Indians. Diabetes. 2005 Jan;54(1): ... The presence or absence of T2DM was established according to the American Diabetes Association criteria (15), in which diabetes ...
Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes. * ... Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes}}, ... type. Contribution to journal publication status. published. subject. *Endocrinology and Diabetes. in Human Molecular Genetics ... Gestational diabetes mellitus (GDM) is associated with increased risk of pregnancy complications and adverse perinatal outcomes ...
In this type, body does not use insulin adequately and become resistant to even... ... Type 2 Diabetes is also called Non Insulin Dependent Diabetes. ... Type 1 Diabetes Research Paper. Like type one diabetes, type ... Type II Diabetes, also known as diabetes mellitus, is also called non-insulin-dependent diabetes or aadult onset diabetes. It ... Diabetes can be divided into two groups: Type 1 diabetes and Type 2 diabetes. Type 1 diabetes is also referred to as juvenile ...
Type 2 diabetes mellitus (T2DM) is one of the common metabolic diseases in the world. Due to the rise in morbidity and ... Type 2 diabetes mellitus (T2DM) is one of the common metabolic diseases in the world. Due to the rise in morbidity and ... Results From the International Diabetes Federation Diabetes Atlas, 9(Th) Edition. Diabetes Res. Clin. Pract. 157, 107843. doi: ... 2020). Gestational Diabetes Mellitus Is Associated With Reduced Dynamics of Gut Microbiota During the First Half of Pregnancy. ...
International Diabetes Federation (IDF) estimates the global prevalence of diabetes to be 425 million. The co-morbidities and ... The global prevalence of Type 2 Diabetes Mellitus (T2DM) has been on the rise over the last four decades and is expected to ... An Investigation into Usability of Big Data Analytics in the Management of Type 2 Diabetes Mellitus. EasyChair Preprint no. ... An Investigation into Usability of Big Data Analytics in the Management of Type 2 Diabetes Mellitus}, howpublished = {EasyChair ...
One of the first steps in the management of patients with type 2 diabetes mellitus is setting glycemic goals. Professional ... Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials Ann Intern Med. 2011 Apr ... One of the first steps in the management of patients with type 2 diabetes mellitus is setting glycemic goals. Professional ... However, somewhat higher targets should be considered for older patients with long-standing type 2 diabetes mellitus and ...
Majority of the patient with type 2 diabetes in Ethiopia are managed by OHA monotherapy mainly glybenclamide and metformine. ... Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia N Am J Med Sci. 2011 ... Background: Type-2 diabetes mellitus and its complication are becoming more prevalent in Ethiopia. Evidence abound that the ... Aims: The aim is to assess adherence to anti diabetic drug therapy and self management practice among type-2 diabetic patient ...
For this reason, the ACP has released updated guidelines for the management of type 2 diabetes with oral medication. ... previously released guidelines in 2012 regarding the effectiveness and safety of oral pharmacologic treatment for type 2 ... diabetes; however, new evidence has emerged and new drugs have been approved by the U.S. Food and Drug Administration. ... Type 2 diabetes mellitus, which occurs in up to 95% of persons with diabetes, is typically managed with lifestyle modifications ...
Hu FB, van Dam RM, Lui S. Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia2001;44:508 ... Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care1997;20:1183-97. ... Food consumption and the incidence of type II diabetes mellitus. Eur J Clin Nutr2005;59:441-8. ... Frequent salad vegetable consumption is associated with a reduction in the risk of diabetes mellitus. J Clin Epidemiol1999;52: ...
i,Objectives.,/i, To assess the efficacy and safety of berberine in the treatment of type 2 diabetes mellitus (T2DM). ,i, ... Y. X. Ni, "Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research," Journal of ... "The therapeutic effects of berberine on 24 hour urinary albumin of type II diabetes mellitus," Chinese Journal of Integrated ... The prevalence of diabetes mellitus (DM) has continued to increase globally. According to the latest figures from the ...
... December 1, 2006. T. Alafia Samuels, MD, MPH, PhD. ... Both types of letters were sent in the same way, and neither specifically advised participants that they appeared to have DM. ... It is well established that 30% to 50% of prevalent cases of type 2 DM are undiagnosed in the United States, but few data are ... Results: Among 298 ARIC participants with incident type 2 DM at visit 2 of the study, the median delay from onset of DM to ...
Finding epigenetic evidence of the relationship between maternal malnutrici n and the development of type two diabetes mellitus ... Currently, diabetes mellitus represents a major public health problem. Its high prevalence and incidence have made it one of ... Haghverdizadeh P, Sadat Haerian M, Haghverdizadeh P, Sadat Haerian B. ABCC8 genetic variants and risk of diabetes mellitus. ... el estatus hormonal del feto y la concentraci n de biomarcadores al nacimiento de diabetes mellitus y s ndrome metab lico. ...
Latent mycobacterium tuberculosis infection among type 2 diabetes mellitus patients. Olanisun Olufemi Adewole, O. Kayode, O. ... Latent mycobacterium tuberculosis infection among type 2 diabetes mellitus patients. Olanisun Olufemi Adewole, O. Kayode, O. ... Latent mycobacterium tuberculosis infection among type 2 diabetes mellitus patients. Olanisun Olufemi Adewole, O. Kayode, O. ... Results: Sixty type 2 diabetic patients and 55 controls similar in age, sex and social class distribution were recruited. Mean ...
Type 2 diabetes mellitus (T2DM) related cognitive declines are associated with neuroimaging changes in the brain. However, only ... Type 2 diabetes mellitus (T2DM)-related cognitive decline is associated with neuroimaging changes. However, only a few studies ... Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. ... other types of diabetes, and contraindications to MRI were excluded. Finally, a total of 38 HC subjects and 34 T2DM subjects ...
Keywords: Diabetes mellitus, Body Mass Index, Lipid profile. ... Keywords: Diabetes mellitus, Body Mass Index, Lipid profile. ... Conclusion: The result indicates dyslipidemia in diabetes. Adequate and proper management of diabetes to reduce dyslipidemia ... Conclusion: The result indicates dyslipidemia in diabetes. Adequate and proper management of diabetes to reduce dyslipidemia ... Results: The TC, TG, LDL-C, VLDL-C as well as BMI of diabetes were observed to be significantly high (P<0.05) when compared ...
UK Prospective Diabetes Study 16. Overview of 6 years therapy of type II diabetes: a progressive disease. Diabetes 1995;44: ... Can J Diabetes 2008;32 Suppl 1: i-S201. Available: www.diabetes.ca/files/cpg2008/cpg-2008.pdf (accessed 2011 July 4).. ... Computer modeling of diabetes and its complications: a report on the fourth Mount Hood Challenge Meeting. Diabetes Care 2007;30 ... Prevalence, total and excess costs of diabetes and related complications in Ontario, Canada. Can J Diabetes 2009;33:35-45. ...
Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am J Psychiatry 2000; 157: ... New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment. Psychosomatics 1999; 40: 438-43. ... Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry 2001; 46: 273-81. ... Diagnosis, classification, and pathogenesis of diabetes mellitus. J Clin Psychiatry 2001; 62(Suppl 27): 5-9. ...
... is mainly recommended to help improve blood glucose levels in patients with type 2 diabetes mellitus (T2DM). However, a low- ... Chinese Diabetes Society. Guidelines for the prevention and treatment of type 2 diabetes in China. Chin. Med. J. 2017, 10, 4-67 ... diabetes mellitus; diet; carbohydrate; blood glucose; HbA1c; fasting blood glucose; postprandial blood glucose ... Dietary intervention is a strategy to manage diabetes mellitus (DM) [1], as it can reduce the burden on islet cells and thus ...
The vast majority of diabetes mellitus patients can be classified as having either Type 1 Diabetes Mellitus (T1DM) or Type 2 ... Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia - high blood glucose levels - that ... Diabetes Mellitus (T2DM). Approximately 90-95% of all diabetics have T2DM. ... The vast majority of diabetes mellitus patients can be classified as having either Type 1 Diabetes Mellitus (T1DM) or Type 2 ...
... is one of the most common complications of diabetes and has been associated with cardiovascular disease, the leading c ... American Diabetes A. Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes. 2015;33(2): ... American Diabetes Association. Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes ... Eighty-two adult subjects with diagnosed T2DM were recruited from the Diabetes Mellitus Outpatient Clinic of the 3rd Department ...
This study investigated differences in suicide and all-cause mortality from comorbid major depression and type 2 DM depending ... Increasing evidence has indicated a relationship between depression and diabetes mellitus (DM). ... Depression and risk for onset of type II diabetes. a prospective population-based study. Diabetes Care. 1996;19(10):1097-1102. ... IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; ...
Most pediatric patients with type 2 diabetes belong to minority communities. ... Although type 2 diabetes is widely diagnosed in adults, its frequency has markedly increased in the pediatric age group since ... Guideline] Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004 Jan. 27 Suppl 1:S5-S10. [QxMD MEDLINE Link]. ... independent of the type of diabetes. [37] Albuminuria is a risk factor for renal failure in pediatric type 2 diabetics. Youth ...
Diabetes risk factors are well known. In this work we proposed to study the role of genetic polymorphism of the eNOS G894T gene ... Methods: We conducted a prospective case-control study in which we included 200 subjects divided into 100 patients with type 2 ... in type 2 diabetes compared with controls. The mutated genotypes of GT eNOS gene was significantly more frequent in diabetic ... diabetes and 100 controls in apparent good health. For each patient and control we measured lipid parameters, CRP-us and sought ...
Individuals with severe mental illness or type 2 diabetes mellitus (T2DM) have increased levels of peripheral immune- ... Immune-inflammatory biomarkers higher in severe mental illness, type 2 diabetes mellitus. ... Individuals with severe mental illness or type 2 diabetes mellitus (T2DM) have increased levels of peripheral immune- ... Citation: Immune-inflammatory biomarkers higher in severe mental illness, type 2 diabetes mellitus (2022, August 11) retrieved ...
  • Transcription factor 7-like 2 ( TCF7L2 ) variants have been associated with type 2 diabetes mellitus (T2DM) in multiple ethnic groups. (medscape.com)
  • There was no significant difference in allele and genotype frequencies of +276G>T between type T2DM patients and controls. (who.int)
  • Type 2 diabetes mellitus (T2DM) is one of the common metabolic diseases in the world. (frontiersin.org)
  • Type 2 diabetes mellitus (T2DM) is a progressive metabolic disease characterized by pancreatic β-cell dysfunction and peripheral insulin resistance, leading to defects in glucose metabolism and chronic low-grade inflammation. (frontiersin.org)
  • The global prevalence of Type 2 Diabetes Mellitus (T2DM) has been on the rise over the last four decades and is expected to rise further. (easychair.org)
  • August 1, 2014 - The FDA has approved Jardiance (empagliflozin) tablets in conjunction with diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM). (pharmacytimes.com)
  • To assess the efficacy and safety of berberine in the treatment of type 2 diabetes mellitus (T2DM). (hindawi.com)
  • Type 2 diabetes mellitus (T2DM) is the most common form of diabetes. (hindawi.com)
  • Initial therapy for treating T2DM includes diet and exercise, followed by the use of oral hypoglycemic agents and potentially subcutaneous insulin injections [ 1 , 2 ]. (hindawi.com)
  • Type 2 diabetes mellitus (T2DM)-related cognitive decline is associated with neuroimaging changes. (frontiersin.org)
  • Type 2 diabetes mellitus (T2DM) is a systemic metabolic disease, resulting in severe complications of multiple systems. (frontiersin.org)
  • Objective: In China, a low-fat diet (LFD) is mainly recommended to help improve blood glucose levels in patients with type 2 diabetes mellitus (T2DM). (mdpi.com)
  • The vast majority of diabetes mellitus patients can be classified as having either Type 1 Diabetes Mellitus (T1DM) or Type 2 Diabetes Mellitus (T2DM). (sbwire.com)
  • Consider market opportunities and potential risks by examining trends in T2DM clinical trial size, duration, and failure rate by stage of development, molecule type, and mechanism of action. (sbwire.com)
  • Eighty-two adult subjects with diagnosed T2DM were recruited from the Diabetes Mellitus Outpatient Clinic of the 3rd Department of Internal Medicine, situated at Papageorgiou General Hospital, Thessaloniki, Greece, and divided into two groups according to the presence or absence of DPN. (springer.com)
  • This study investigated differences in suicide and all-cause mortality from ICD-9-CM comorbid major depressive disorder (MDD) and type 2 diabetes mellitus (T2DM) depending on which was diagnosed first. (psychiatrist.com)
  • Patients with newly diagnosed T2DM were identified and further classified into 3 groups: (1) MDD before T2DM, (2) T2DM without any diagnosis of MDD (from which matched controls were selected), and (3) MDD after T2DM, based on the sequential occurrence dates between incident T2DM and MDD. (psychiatrist.com)
  • Individuals with severe mental illness or type 2 diabetes mellitus (T2DM) have increased levels of peripheral immune-inflammatory biomarkers, which may contribute to neurocognitive and social deficits, according to a study recently published in the Frontiers of Neurology . (medicalxpress.com)
  • Introduction Type 2 diabetes mellitus (T2DM) is a highly prevalent chronic disease in the Spanish population. (bmj.com)
  • We analyzed the association between adherence of a MeDiet in patients with type 2 diabetes mellitus (T2DM) and levels of HbA1c. (nuthealth.org)
  • The aim of this study was therefore to evaluate the plasma levels of FABP3 at different stages of estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes mellitus (T2DM). (medsci.org)
  • Background: In China, traditional Chinese medicine (TCM) has been used to treat type 2 diabetes mellitus (T2DM) for centuries. (benthamscience.com)
  • Background: The complex disease of diabetes mellitus type 2 (T2DM) requires a high standard of quality of care. (eur.nl)
  • Clinical practice guidelines define norms for diabetes care that ensure regular monitoring of T2DM patients, including annual diagnostic tests. (eur.nl)
  • As the burden of disease from diabetes rises to epidemic proportions, RGA's Heather Lund asks in On the Risk whether the possibility of remission for Type 2 diabetes mellitus (T2DM) signals an opportunity to escape a major public health traffic jam. (rgare.com)
  • But in recent years, despite initial scanty evidence, there is mounting data that suggests some reversibility in established Type 2 diabetes mellitus (T2DM), particularly in those with short duration. (rgare.com)
  • Despite earlier evidence suggesting remission is possible, it is only as recent as 2016 that reference to T2DM reversal was added to the World Health Organization (WHO) Global Report on Diabetes. (rgare.com)
  • BACKGROUND: Type 2 Diabetes Mellitus (T2DM) is a chronic disease that affects millions of people, and according to the International Diabetes Federation, 46.5% of people have undiagnosed diabetes. (galileo-training.com)
  • The reported prevalence of low testosterone among men with type 2 diabetes mellitus (T2DM) is high. (samj.org.za)
  • In a cross-sectional observational study, androgen deficiency symptoms in men with T2DM attending two outpatient diabetes clinics in Durban, KwaZulu-Natal Province, SA, were assessed using the Ageing Males' Symptoms Scale (AMS) questionnaire and direct enquiry. (samj.org.za)
  • Objective: To determine whether inflammatory macrophages contribute to neuropathic pain associated with type 2 diabetes-mellitus (T2DM). (atsbio.com)
  • We investigated the association between alterations in regular physical activity (PA) and the risk of developing AF in patients with type 2 diabetes mellitus (T2DM) and the optimal PA range based on energy expenditure. (diabetesjournals.org)
  • Type 2 diabetes mellitus (T2DM) is a chronic disease that can cause adverse effects if not managed effectively. (researchprotocols.org)
  • The prevalence of T2DM will continue to rise every year, and data from the International Diabetes Federation show that the number of patients diagnosed with T2DM in Indonesia is predicted to increase from 10.3 million in 2017 to 16.7 million in 2045. (researchprotocols.org)
  • Type 2 diabetes mellitus (T2DM) is a frequent co-morbidity, and a negative prognostic risk factor in patients with heart failure and reduced left ventricle ejection fraction (HFrEF), [ 1 ]. (biomedcentral.com)
  • But it shares with type 1 diabetes high blood sugar levels, and the complications of high blood sugar. (harvard.edu)
  • Gestational diabetes mellitus (GDM) is associated with increased risk of pregnancy complications and adverse perinatal outcomes. (lu.se)
  • Complications of diabetes in the long term include potential heart disease, stroke, and kidney damage. (bartleby.com)
  • The limited available evidence suggests that near-normal glycemic targets should be the standard for younger patients with relatively recent onset of type 2 diabetes mellitus and little or no micro- or macrovascular complications, with the aim of preventing complications over the many years of life. (nih.gov)
  • Adequate and proper management of diabetes to reduce dyslipidemia and further complications are therefore recommended. (academicjournals.org)
  • We used the United Kingdom Prospective Diabetes Study Outcomes Model to forecast diabetes-related complications, quality-adjusted life-years and costs of alternative second-line therapies available in Canada for adults with type 2 diabetes inadequately controlled by metformin. (cmaj.ca)
  • Diabetic peripheral neuropathy (DPN) is one of the most common complications of diabetes and has been associated with cardiovascular disease, the leading cause of mortality in diabetes. (springer.com)
  • 4. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. (psychiatrist.com)
  • In this work we proposed to study the role of genetic polymorphism of the eNOS G894T gene in the development of diabetes on the one hand and of these degenerative complications other. (scirp.org)
  • It was reported that there is an increasing rate of type-2 diabetes and its associated complications in the Arabic countries (East Mediterranean, Arabic Peninsula and Northern Africa) 2 . (scialert.net)
  • Uncontrolled diabetes prompts numerous chronic complications such as visual impairment, renal failure and heart failure 7 . (scialert.net)
  • Individuals with type-2 diabetes work proactively to optimize their conditions and well being as well as to reduce complications by using herbs and supplements which are known as complementary and alternative medicine (CAM) treatments 8 . (scialert.net)
  • It was reported that diabetes and its complications were recently upgraded to be the fourth leading cause of death in Libya 11 . (scialert.net)
  • There is good motivation to reverse the metabolic effects and subsequent major complications of diabetes, both for the individual and society. (rgare.com)
  • Is there any evidence to support an associated reduction in diabetes complications? (rgare.com)
  • One of the most common complications of diabetes mellitus is loss of peripheral sensation. (galileo-training.com)
  • This trend is a serious threat to public health, as diabetes is associated with severe and potentially fatal complications and comorbidities, such as cardiovascular disease, kidney disease, visual impairment, neuropathies, and infectious complications. (cdc.gov)
  • The person living with diabetes can experience symptoms from such comorbidities which may impact function, emotional well-being, and quality of life as well as morbidity from complications that may limit work productivity, increase absenteeism, and lead to premature loss of employment. (cdc.gov)
  • The prevalence of diabetes mellitus (DM) has continued to increase globally. (hindawi.com)
  • Habitual chocolate intakes, measured using a food frequency questionnaire, were related to prevalence of diabetes mellitus (cross-sectionally) and with risk of diabetes measured approximately five years later (prospectively). (umaine.edu)
  • Jardiance should not be used to treat individuals with type 1 diabetes mellitus, diabetic ketoacidosis, severe renal impairment, or end-stage renal disease, or in patients on dialysis. (pharmacytimes.com)
  • New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment. (jabfm.org)
  • A lean patient who has had diabetes since childhood, who has always been dependent on insulin, or who has a history of diabetic ketoacidosis (DKA) almost certainly has type 1 diabetes. (medscape.com)
  • Most pediatric patients with type 2 diabetes belong to minority communities. (medscape.com)
  • One of the first steps in the management of patients with type 2 diabetes mellitus is setting glycemic goals. (nih.gov)
  • Jardiance provides an additional treatment option for the care of patients with type 2 diabetes,' said Curtis J. Rosebraugh, MD, MPH, director of the Office of Drug Evaluation II in the FDA's Center for Drug Evaluation and Research. (pharmacytimes.com)
  • There is dearth of data on the prevalence of latent tuberculosis infection among patients with type 2 diabetes. (ersjournals.com)
  • Metformin is widely accepted as first-line pharmacotherapy for patients with type 2 diabetes mellitus when glycemic control cannot be achieved by lifestyle interventions alone. (cmaj.ca)
  • For most patients with type 2 diabetes that is inadequately controlled with metformin monotherapy, the addition of a sulphonylurea represents the most cost-effective second-line therapy. (cmaj.ca)
  • 8 As part of a larger initiative to determine optimal prescribing of antihyperglycemic agents, we sought to determine the incremental cost-effectiveness of treatment with alternative second-line agents added to metformin in patients with type 2 diabetes no longer adequately controlled by metformin monotherapy. (cmaj.ca)
  • As asymptomatic myocardial ischemia (MI) is frequent in diabetes, we hypothesized that DPN may be associated with MI in patients with type 2 diabetes mellitus and no history of cardiovascular events. (springer.com)
  • Mortality of patients with type 2 diabetes in Taiwan: a 10-year nationwide follow-up study. (psychiatrist.com)
  • Major depressive disorder in patients with type 2 diabetes mellitus: prevalence and clinical characteristics. (psychiatrist.com)
  • Methods: We conducted a prospective case-control study in which we inclu ded 200 subjects divided into 100 patients with type 2 diabetes and 100 controls in apparent good health. (scirp.org)
  • Marta Garés-Caballer et al, Immune-Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up Study, Frontiers in Neurology (2022). (medicalxpress.com)
  • Adherence to the mediterranean diet in patients with type 2 diabetes mellitus and HbA1c Level. (nuthealth.org)
  • What is recommended for optimal glycemic control in patients with type 2 diabetes at diagnosis and obviously as they progress? (medicaleconomics.com)
  • Acute Effects of a Whole Body Vibration Session on the Vibration Perception Threshold in Patients with Type 2 Diabetes Mellitus. (galileo-training.com)
  • As previously stated, patients with type 2 diabetes mellitus can usually be differentiated from those with type 1 disease on the basis of history and physical examination findings and through simple laboratory tests. (medscape.com)
  • Patients with type 2 diabetes are generally obese, and may have acanthosis nigricans and/or hirsutism in conjunction with thick necks and chubby cheeks. (medscape.com)
  • Nutrients and Dietary Approaches in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Narrative Review. (scienceplay.com)
  • Quality of measurement properties of medication adherence instruments in cardiovascular diseases and type 2 diabetes mellitus: a systematic review and meta-analysis. (bvsalud.org)
  • Researchmoz added Most up-to-date research on 'Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth' to its huge collection of research reports. (sbwire.com)
  • Received: 14 Nov. 2022 improving self-management of type 2 diabetes, especially in a South African context. (who.int)
  • Evidence abound that the most important predictor of reduction of morbidity and mortality due to diabetes complication is the level of glycemic control achieved. (nih.gov)
  • Metformin monotherapy is widely recommended as first-line pharmacotherapy, 1 , 2 given its favourable effects in controlling blood glucose and body weight, low risk of hypoglycemia, low cost and association with mortality benefit. (cmaj.ca)
  • Depression and mortality in type 2 diabetes mellitus. (psychiatrist.com)
  • Diabetes constitutes one of the major independent cardiovascular risk factors, and patients with this disease suffer from premature cardiovascular morbidity and mortality. (scirp.org)
  • Patients with CKD are at a high risk of cardiovascular disease and mortality and are associated with increased treatment costs [ 2 ]. (medsci.org)
  • Diabetes causes significant morbidity and premature mortality. (rgare.com)
  • Medication adherence has a major impact on reducing mortality and healthcare costs related to the treatment of cardiovascular diseases and diabetes mellitus . (bvsalud.org)
  • Physical inactivity increases all causes of mortality, doubles the risks of cardiovascular diseases, type 2 Diabetes and obesity. (who.int)
  • Cardiovascular diseases, diabetes, cancer, and chronic respiratory diseases account for 70% of the burden of NCDs in the Region.3 The Region also has a high burden of severe NCDs, which are those that result in significant loss of healthy life for affected individuals due to early and high levels of disability and mortality in the absence of treatment. (who.int)
  • The aim is to assess adherence to anti diabetic drug therapy and self management practice among type-2 diabetic patient in Ethiopia. (nih.gov)
  • A cross-sectional review of randomly selected 384 case notes of type-2 diabetic patient that attend diabetes mellitus clinic over 3 month and cross-sectional interview, with pre tested adherence and self management and monitoring tool questioner of 347 consecutive patients that attend in Jimma university specialized hospital diabetic clinic. (nih.gov)
  • Guideline adherence was measured by comparing structure and process indicators of care with recommendations in the national diabetes care guideline. (eur.nl)
  • Conclusions: Guideline adherence in Dutch general practices offering diabetes care was not optimal. (eur.nl)
  • This study aims to critically assess, compare and synthesize the quality of the measurement properties of patient-reported outcome measures to assess medication adherence among patients with cardiovascular diseases and/or type 2 diabetes mellitus . (bvsalud.org)
  • Type 2 diabetes is a chronic disease. (harvard.edu)
  • Introduction: Diabetes mellitus is a chronic disease whose global expansion gives it the characteristics of a pandemic. (scirp.org)
  • Exclusion criteria included diabetes mellitus and advanced chronic disease. (bmj.com)
  • Diagnosis, classification, and pathogenesis of diabetes mellitus. (jabfm.org)
  • Insulin supersensitivity and normoinsulinaemic hypoglycaemia might play a role in clinical manifestation and pathogenesis of type 2 DM. (bmj.com)
  • In January 2013, the American Academy of Pediatrics (AAP) issued clinical practice guidelines on the management of type 2 diabetes in children and adolescents. (medscape.com)
  • The individualization of HbA(1c) targets has gained more traction after recent clinical trials in older patients with established type 2 diabetes mellitus failed to show a benefit from intensive glucose-lowering therapy on cardiovascular disease (CVD) outcomes. (nih.gov)
  • Exposures were demographic, socioeconomic, health behavior, and clinical risk factors before the onset of type 2 DM. (ajmc.com)
  • Type 2 diabetic patients attending medical outpatient clinic in a Specialist Hospital in Nigeria and apparently healthy controls matched for age and sex were recruited.Socio demographic and clinical data were obtained through a pro forma. (ersjournals.com)
  • Diabetes mellitus is a clinical syndrome characterized by hyperglycemia due to absolute or relative deficiency of insulin. (academicjournals.org)
  • Recent clinical practice guidelines, including those produced by the Canadian Diabetes Association 1 and by the American Diabetes Association and the European Association for the Study of Diabetes, 2 have suggested selecting from among several agents on the basis of their respective advantages and disadvantages. (cmaj.ca)
  • Throughout the years, diabetes mellitus (DM) has risen as an essential clinical and public medical issue throughout the world. (scialert.net)
  • 5 However, a recent position statement from the Association of British Clinical Diabetologists (ABCD) and the Primary Care Diabetes Society (PCDS) suggests a single definition, using the higher WHO threshold for diabetes as its defining biochemical criterion sustained over a shorter period, including the need for weight loss. (rgare.com)
  • We have the ADA [American Diabetes Association] Standards of Medical Care in Diabetes, and we have the AACE [American Association of Clinical Endocrinology] Clinical Practice Guidelines. (medicaleconomics.com)
  • To determine the clinical changes occurred in chronic periodontitis patients presenting uncontrolled type 2 diabetes mellitus after a supragingival plaque control period. (bvsalud.org)
  • To evaluate clinical outcomes in patients with diabetes, treated by cardiac resynchronization therapy with a defibrillator (CRT-d), and glucagon-like peptide 1 receptor agonists (GLP-1 RA) in addition to conventional hypoglycemic therapy vs. CRTd patients under conventional hypoglycemic drugs. (biomedcentral.com)
  • Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. (jabfm.org)
  • Methods and analysis A multicentre quasi-experimental design comparing a group of individuals taking part in the intervention (intervention group (IG)) with a similar group receiving standard diabetes care (comparison group (CG)) is planned. (bmj.com)
  • Material and research methods: We for the period from January, 01.2017 to December, 31, 2017 year 102 patients with type 1 and type 2 diabetes mellitus were examined. (endocrine-abstracts.org)
  • The methods used to assess the conditions have changed during the pandemic as the amount of literature and types of studies increased. (cdc.gov)
  • Materials and Methods: The study was done as a cross‑sectional study in a tertiary care medical college hospital for 2 years among 218 adults patients of both sexes with type 2 diabetes mellitus. (who.int)
  • The symptoms of diabetes are related to high blood glucose levels. (harvard.edu)
  • The treatment of type 2 diabetes also can produce symptoms. (harvard.edu)
  • The use of the term diabetes "remission" is preferred, as it best reflects the improved symptoms and biochemical status. (rgare.com)
  • A 60-year-old man with uncontrolled type 2 diabetes mellitus (DM) (glycated haemoglobin 11%) had the unusual symptoms of palpitations and sweating after drinking an excessive amount of soft drinks. (bmj.com)
  • The association of NAFLD in type 2 diabetes mellitus patients with symptoms of angina according to modified rose and ECG changes using Minnesota codes was studied. (who.int)
  • Diabetes describes a group of metabolic diseases in which the person has high blood glucose because insulin production is inadequate, or because the body 's cells do not respond properly to insulin, or both. (bartleby.com)
  • Albany, NY -- ( SBWIRE ) -- 09/19/2016 -- Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia - high blood glucose levels - that results from defects in insulin secretion, insulin action, or a combination of these. (sbwire.com)
  • We used the United Kingdom Prospective Diabetes Study Outcomes Model 9 to conduct an incremental cost-utility analysis comparing alternative second-line therapies for adults with type 2 diabetes inadequately controlled by metformin. (cmaj.ca)
  • The objective of the study was to explore the views and experiences of adults with type 2 diabetes mellitus on a nutrition education programme. (ajol.info)
  • The study subjects were adults with type 2 diabetes mellitus ( n = 41, aged 40-70 years) participating in a nutrition education intervention (one-year randomised controlled trial). (ajol.info)
  • Diabetes is a pivotal cause of asymptomatic myocardial ischemia (MI) even in the absence of coronary artery disease [ 3 ]. (springer.com)
  • This study was done to assess the association of NAFLD with coronary artery disease (CAD) in type 2 diabetes mellitus. (who.int)
  • Conclusion: There is significant association of coronary artery disease and cardiovascular risk factors with NAFLD in type 2 diabetes. (who.int)
  • We're now in a different world where we have diabetes drugs that can lower macrovascular disease. (medicaleconomics.com)
  • Persons with prediabetes are at increased risk for macrovascular disease, as well as diabetes. (medscape.com)
  • None of the included PROMs met the criteria for being classified as trusted and recommended for use for patients with cardiovascular diseases and/or type 2 diabetes mellitus . (bvsalud.org)
  • Guideline] Diagnosis and classification of diabetes mellitus. (medscape.com)
  • Guideline] American Diabetes Association. (medscape.com)
  • and Robbins, Michael A., "Habitual chocolate intake and type 2 diabetes mellitus in the Maine-Syracuse Longitudinal Study: (1975-2010): Prospective observations" (2016). (umaine.edu)
  • The Lancet Diabetes & Endocrinology. (medigraphic.com)
  • 2 Republican Specialized Scientific Practical Medical Center of Endocrinology of Public Health Ministry named by acad. (endocrine-abstracts.org)
  • The review summarised the techniques that have proven to be effective for the Published: 29 May 2023 self-management of type 2 diabetes. (who.int)
  • Once a diagnosis of type 2 diabetes is confirmed, lifestyle modification and metformin treatment should be initiated. (medscape.com)
  • GDM often reoccurs and is associated with increased risk of subsequent diagnosis of type 2 diabetes (T2D). (lu.se)
  • The prevalence of diabetes is currently estimated to be about 6.4% worldwide, 1 and in the past two decades alone there has been a dramatic increase in the diagnosis of type 2 diabetes. (bmj.com)
  • The diagnosis of diabetes can be made by identifying hyperglycemia. (scienceplay.com)
  • IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. (psychiatrist.com)
  • Diabetes Metab J . 2017;41(4):263-264. (psychiatrist.com)
  • and Diabetics (n=14) - subjects with uncontrolled type 2 diabetes mellitus presenting chronic periodontitis. (bvsalud.org)
  • Famines in the Last 100 Years: Implications for Diabetes. (medigraphic.com)
  • Increased use of newer, more costly agents, along with the rising incidence of type 2 diabetes, carries significant budgetary implications for health care systems. (cmaj.ca)
  • Because type 2 diabetes in children and adolescents is strongly associated with obesity and sedentary lifestyle, any intervention designed to increase physical activity and improve dietary habits should be encouraged. (medscape.com)
  • Obesity greatly increases the risk of diabetes. (harvard.edu)
  • Strong evidence shows that unhealthy diet and insufficient physical activity are among the major causal risk factors in coronary heart disease, cerebrovascular strokes, several forms of cancer, type 2 diabetes, hypertension, obesity, osteoporosis, dental caries, and other conditions. (who.int)
  • The hazards of overweight and obesity to the health of individuals and populations were demonstrated in a recent WHO report.1 Besides changes in body weight, diet and physical activity are linked to noncommunicable diseases through other mechanisms such as links between type of fat and low-density lipoprotein cholesterol, and between salt intake and blood pressure, often in people whose body weight is within normal range. (who.int)
  • Physical activity is essential for preventing and controlling risk factors and chronic diseases, such as diabetes, high blood pressure (HBP), cardiovascular disease (CVD), obesity, cancer, and depression (1). (cdc.gov)
  • Some studies indicate that proximity to green spaces is linked to a lower risk of HBP, improved diabetes outcomes, and reduced obesity (4-8). (cdc.gov)
  • Only 5% of people with diabetes have this form of the disease. (bartleby.com)
  • It is a burden on health care systems and costly to treat - with international figures showing medical costs for people with diabetes are two-to-threefold greater, when compared with those without diabetes. (rgare.com)
  • Participants also recommended the programme to other people with diabetes mellitus. (ajol.info)
  • We conducted this analysis to determine the relative costs, benefits and cost-effectiveness of options for second-line treatment of type 2 diabetes. (cmaj.ca)
  • In contrast, treatment of type 2 diabetes consists of lifestyle measures and a variety of other medications, with insulin introduced if those prove inadequate. (medscape.com)
  • Type-2 diabetes mellitus and its complication are becoming more prevalent in Ethiopia. (nih.gov)
  • Diabetic peripheral neuropathy (DPN) is the most prevalent neuropathy in diabetes and a common cause of morbidity. (springer.com)
  • The cause of type 2 diabetes is directly related to overweight, sedentary lifestyle, elevated triglycerides, hypertension, altered lipid profile, polycystic ovary syndrome, and inadequate eating habits. (scienceplay.com)
  • Its fundamental importance in energy balance and weight control and in reducing the risks of coronary heart disease, stroke, hypertension, diabetes, colon cancer, breast cancer, and depression has been widely recognized. (who.int)
  • 1 diabetes mellitus, insulin-dependent type 2 diabetes, advanced rheumatic heart disease, cardiomyopathy, severe hypertension and moderate to severe persistent asthma. (who.int)
  • If glycemic control needs to be improved with medication in persons with type 2 diabetes, metformin should be prescribed because it can efficiently lower glycemic levels, is linked to losing weight and fewer occurrences of hypoglycemia, and is generally less expensive than other options. (aafp.org)
  • These therapies provide reasonable durable glycemic control but are unable to arrest the natural progression of diabetes or the eventual need for insulin. (bvsalud.org)
  • Objective To investigate the independent effects of intake of fruit and vegetables on incidence of type 2 diabetes. (bmj.com)
  • Study selection Prospective cohort studies with an independent measure of intake of fruit, vegetables, or fruit and vegetables and data on incidence of type 2 diabetes. (bmj.com)
  • There has been a focus on the role of carbohydrates and fibre, 2 3 but the relation between fruit and vegetable intake and incidence of type 2 diabetes is not fully understood. (bmj.com)
  • Type 2 diabetes is the most common, people with Type 2 diabetes have insulin resistance meaning the body does not use insulin properly. (bartleby.com)
  • Metabolic syndrome, thought to be due to insulin resistance, can occur in patients with overtly normal glucose tolerance, prediabetes, or diabetes. (medscape.com)
  • Compounds in cocoa and chocolate have established cardiovascular benefits, including beneficial effects on insulin resistance, a risk factor for type 2 diabetes mellitus. (umaine.edu)
  • Type 2 diabetes occurs when the body does not properly take advantage of the insulin produced, that is, it is associated with insulin resistance. (scienceplay.com)
  • However, somewhat higher targets should be considered for older patients with long-standing type 2 diabetes mellitus and evidence of CVD (or multiple CVD risk factors). (nih.gov)
  • Summary estimates showed that greater intake of green leafy vegetables was associated with a 14% (hazard ratio 0.86, 95% confidence interval 0.77 to 0.97) reduction in risk of type 2 diabetes (P=0.01). (bmj.com)
  • Conclusion Increasing daily intake of green leafy vegetables could significantly reduce the risk of type 2 diabetes and should be investigated further. (bmj.com)
  • 12 13 Diabetes is a strong independent risk factor for cardiovascular disease, 14 and often the conditions exist together, sharing common modifiable risk factors. (bmj.com)
  • 15 As yet no firm conclusions have been made as to whether increasing intake of fruit and vegetables can decrease the risk of type 2 diabetes itself, given the abundance of conflicting evidence within the literature. (bmj.com)
  • Diabetes risk factors are well known. (scirp.org)
  • Type 2 diabetes is a chronic non-transmissible disease, acquired and modifiable with lifestyle factors, despite having an important genetic risk factor. (scienceplay.com)
  • Novel biomarkers of risk, such as apolipoprotein (Apo) A1 and ApoB (2), and the inflammatory markers C-reactive protein (CRP), fibrinogen, and homocysteine (3-5), have been proposed. (cdc.gov)
  • While aging and exposure to loud noise and other ototoxic substances are well-known risk factors for hearing loss, research conducted over the past several decades has brought attention to sensorineural hearing loss among individuals with other health problems such as diabetes. (cdc.gov)
  • For those born in 2000, the estimated lifetime risk for developing diabetes is 32.8% for males and 38.5% for females, and the risk is even higher in certain minority groups. (cdc.gov)
  • Risk factors for type 2 diabetes are complex and include genetic predisposition, lifestyle issues such as insufficient exercise, diet and smoking, as well as environmental components. (cdc.gov)
  • International Diabetes Federation (IDF) estimates the global prevalence of diabetes to be 425 million. (easychair.org)
  • According to the latest figures from the International Diabetes Federation (IDF), the number of individuals with diabetes in 2011 has reached a staggering 366 million, causing 4.6 million deaths each year. (hindawi.com)
  • Finding epigenetic evidence of the relationship between maternal malnutrici n and the development of type two diabetes mellitus is achieved not only decrease the incidence rate of the disease, preventing maternal malnutrition, but also progress in treatment studies towards of the problem target as for epigenetics it is discussed. (medigraphic.com)
  • Liraglutide, a glucagonlike peptide-1 (GLP-1) agonist, is the first noninsulin drug approved to treat type 2 diabetes in pediatric patients since metformin was approved for pediatric use in 2000. (medscape.com)
  • Metformin should be the first medication prescribed for diabetes when an oral agent is required. (aafp.org)
  • Because combination treatment has been shown to be superior to metformin alone for decreasing A1C levels, weight, and blood pressure, adding a sulfonylurea, thiazolidinedione, or sodium glucose cotransporter-2 (SGLT-2) or dipeptidyl peptidase-4 (DPP-4) inhibitor can be considered when additional oral treatment is being discussed. (aafp.org)
  • However, uncertainty exists regarding the optimal second-line therapy for patients whose diabetes is inadequately controlled by metformin monotherapy. (cmaj.ca)
  • Type 2 diabetes mellitus, which occurs in up to 95% of persons with diabetes, is typically managed with lifestyle modifications (e.g., diet, exercise) and medication (e.g., oral drugs). (aafp.org)
  • For this reason, the ACP has released updated guidelines for the management of type 2 diabetes with oral medication. (aafp.org)
  • The Dietary Supplement and Prescription Medication section of the Sample Person (SP) Questionnaire collects information on: 1) dietary supplements, 2) nonprescription antacids, 3) prescription medications, and 4) preventive aspirin use. (cdc.gov)
  • Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. (medscape.com)
  • The guidelines recommend insulin treatment in all patients who present with ketosis or extremely high blood glucose levels because it may not be clear initially whether these patients have type 2 or type 1 diabetes. (medscape.com)
  • Type 2 diabetes occurs when your body's cells resist the normal effect of insulin, which is to drive glucose in the blood into the inside of the cells. (harvard.edu)
  • However, over time your pancreas is not able to keep up and can not make enough insulin to keep your blood glucose at normal levels(www.diabetes.org). (bartleby.com)
  • The use of Jardiance--a sodium glucose co-transporter 2 inhibitor--blocks the reabsorption of glucose by the kidneys, increasing glucose excretion and lowering the blood glucose level in patients with diabetes who have an elevated blood glucose level. (pharmacytimes.com)
  • To accomplish ideal glucose control, complex treatment anticipates individuals with type-2 diabetes may include day by day blood glucose testing and checking, fittingly endorsed solutions, for example, oral hypoglycemic agents and/or insulin infusion, nutrition treatment and standard exercise 3 - 5 . (scialert.net)
  • Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. (bmj.com)
  • QUESTION: In patients with impaired glucose tolerance, is a lifestyle intervention programme effective for preventing type 2 diabetes mellitus? (bmj.com)
  • Pre-diabetes (impaired glucose regulation) is known to be reversible. (rgare.com)
  • Prediabetes is defined by a fasting blood glucose level of 100-125 mg/dL or a 2-hour post-oral glucose tolerance test (post-OGTT) glucose level of 140-200 mg/dL. (medscape.com)
  • Type 2 Diabetes Mellitus (DM2) is associated to cognitive and functional deficits and, one of the tools, which can be used to assess executive functions, is the WCST. (bvsalud.org)
  • 29 million people in the United States (9.3 percent) have diabetes, and of those 29 million approximately 7.25 million are unaware that they are diabetic (www.cdc.gov). (bartleby.com)
  • It affects approximately 20-40% of patients with diabetes mellitus and is recognized as the most common cause of end-stage renal disease (ESRD) [ 1 ]. (medsci.org)
  • Unless an acute complication (eg, recurrent hypoglycemia, persistent ketosis, hyperglycemic hyperosmolar state) occurs or there is poor patient compliance with treatment, type 2 diabetes is usually managed in an outpatient setting. (medscape.com)
  • The most common type is peripheral neuropathy. (harvard.edu)
  • Simplified scheme for the pathophysiology of type 2 diabetes mellitus. (medscape.com)
  • To improve our understanding of the aetiological factors and molecular processes driving the occurrence of GDM, including the extent to which these overlap with T2D pathophysiology, the GENetics of Diabetes In Pregnancy (GenDIP) Consortium assembled genome-wide association studies (GWAS) of diverse ancestry in a total of 5485 women with GDM and 347 856 without GDM. (lu.se)
  • Health care services for severe NCDs such as type 1 diabetes, advanced rheumatic heart disease, and sickle cell disease, are usually provided at tertiary facilities in most countries. (who.int)
  • The prevalence of latent tuberculosis infection is high among type 2 diabetic patients. (ersjournals.com)
  • Our objectives were (1) to quantify delay times and (2) to identify factors that predict longer delays. (ajmc.com)
  • Currently, diabetes mellitus represents a major public health problem. (medigraphic.com)
  • The association between depression, quality of life, and the health care expenditure of patients with diabetes mellitus in Uganda. (psychiatrist.com)
  • For correspondence: Professor J Tuomilehto, National Public Health Institute, Department of Epidemiology and Health Promotion, Diabetes and Genetic Epidemiology Unit, Mannerheimintie 166, FIN-00300 Helsinki, Finland. (bmj.com)
  • In a nationwide database, subjects who underwent health examinations twice at a 2-year interval between 2009 and 2012 were studied. (diabetesjournals.org)
  • 2014). In developing countries, this adjustment is further complicated by a change in food consumption patterns, reduced physical activity, a lack of knowledge regarding diabetes, poor access to health systems, migration, urbanisation, and under-resourced healthcare systems (Misra et al. (who.int)
  • Considering both hearing loss and diabetes mellitus are significant health issues, it is worthwhile to examine the relationship between the two. (cdc.gov)
  • 2. Since 2008, WHO has been providing support to Member States to implement the WHO Package of Essential NCD interventions for primary health care in low-resource settings (WHO PEN). (who.int)
  • A recent meta-analysis concluded that there is overwhelming support for the benefit of lifestyle interventions to prevent type 2 diabetes. (bmj.com)
  • How can diet prevent type 2 diabetes? (scienceplay.com)
  • When dealing with patients with known diabetes in the emergency department, distinguishing the type of diabetes can be difficult in 2 groups: (1) patients who are treated with insulin and are young but clinically appear to have type 2 diabetes, and (2) older patients with late-onset of diabetes who nonetheless take insulin and seem to share characteristics of patients with type 1 diabetes. (medscape.com)
  • To estimate delays to physician diagnosis of incident cases of type 2 diabetes mellitus (DM) and to identify predictors of delayed diagnosis. (ajmc.com)
  • individuals with type 2 diabetes. (who.int)